Psychiatric disorder
MONDO:0002025A disorder characterized by behavioral and/or psychological abnormalities, often accompanied by physical symptoms. The symptoms may cause clinically significant distress or impairment in social and occupational areas of functioning. Representative examples include anxiety disorders, cognitive disorders, mood disorders and schizophrenia.
Also known as: Psychiatric disease, Psychiatric disorder, disease of mental health, mental disorder, mental dysfunction, mental illness
10445 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
Showing the 400 most recently updated of 1616 trials in this tab.
-
Could a seizure drug curb alcohol cravings? new trial investigates
Disease control OngoingThis phase 2 trial tests whether zonisamide, a drug currently used for seizures, can help adults with alcohol use disorder drink less. About 205 treatment-seeking participants will receive either zonisamide or a placebo, along with standard support. The study measures alcohol con…
Phase: PHASE2 • Sponsor: Washington State University • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New study aims to help HIV patients manage substance use and stay on track with meds
Disease control OngoingThis study tests a new program to help people with HIV who also use substances stick to their HIV medications and stay in care. The program teaches coping skills and ways to manage substance use. Researchers want to see if the program is practical and acceptable to participants. …
Phase: NA • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Food delivery plus counseling may help rural smokers kick the habit
Disease control OngoingThis study tests whether combining home food delivery with video-based smoking cessation counseling helps rural smokers quit more than counseling or food delivery alone. Participants are adults aged 21-75 who smoke regularly and live in certain Arkansas counties. The goal is to s…
Phase: NA • Sponsor: University of Arkansas • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could a cholesterol drug boost reading skills in kids with NF1?
Disease control OngoingThis study investigates whether combining the medication lovastatin with intensive reading tutoring can improve reading abilities in children and young adults (ages 8-20) with Neurofibromatosis Type 1 (NF1) who have reading disabilities. Participants first receive either lovastat…
Phase: PHASE2 • Sponsor: Vanderbilt University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Can more intensive therapy replace anxiety meds for kids?
Disease control OngoingThis study tests whether a longer, family-involved form of cognitive behavioral therapy (CBT) can work as well as CBT combined with an antidepressant (SSRI) for children and teens with anxiety disorders. Participants aged 7 to 17 with separation, generalized, or social anxiety wi…
Phase: PHASE3 • Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Magnetic pulses aim to lift depression in bipolar II
Disease control OngoingThis study tests whether a rapid form of brain stimulation, called accelerated intermittent theta-burst stimulation (aiTBS), can relieve depression in people with bipolar II disorder whose depression has not responded to other treatments. Participants receive either real or sham …
Phase: NA • Sponsor: Stanford University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could a gentler ICU environment boost brain development in heart babies?
Disease control OngoingThis study tests a behavioral program called Individualized Developmental Care (NIDCAP) for newborns with complex congenital heart disease. The program aims to reduce stress from the hospital environment by supporting parent involvement, creating a soothing setting, and adjusting…
Phase: NA • Sponsor: Boston Children's Hospital • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Money and mind: can financial coaching ease mental health struggles after incarceration?
Disease control OngoingThis study tests whether combining one-on-one financial coaching with access to safe, affordable banking services can improve both financial health and mental well-being for people recently released from jail or prison. Participants, who self-identify as having mental health or s…
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Zapping the brain to curb meth cravings: new trial launches
Disease control OngoingThis study tests a non-invasive brain stimulation technique called targeted temporal interference stimulation (tTIS) aimed at the caudate nucleus. The goal is to reduce drug cravings and improve decision-making in 60 adults with methamphetamine use disorder. Participants will rec…
Phase: NA • Sponsor: Shanghai Mental Health Center • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Could a quicker wean reduce opioid exposure in newborns?
Disease control OngoingThis study compares a rapid weaning schedule to a slower one for newborns being treated with morphine or methadone for neonatal opioid withdrawal syndrome (NOWS). The goal is to see if a faster wean can reduce the number of days babies need opioid medication. The trial includes f…
Phase: PHASE3 • Sponsor: Advancing Clinical Trials in Neonatal Opioid Withdrawal (ACT NOW) Program • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Can skipping opioids during surgery curb addiction? new trial aims to find out
Disease control TerminatedThis study will test whether using opioid-free anesthesia during knee replacement surgery can reduce the risk of long-term opioid use and chronic pain. About 700 adults scheduled for knee replacement will be randomly assigned to receive either standard opioid-based anesthesia or …
Phase: EARLY_PHASE1 • Sponsor: Jacques E. Chelly • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Could a natural hormone rebuild brains in Alzheimer's?
Disease control OngoingThis phase 2 trial tests whether allopregnanolone, a natural hormone, can safely help repair the brain in people with early Alzheimer's disease. About 100 volunteers aged 55 to 80 will receive weekly infusions of the drug or a placebo for several months. Researchers will measure …
Phase: PHASE2 • Sponsor: University of Arizona • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Could a spinal injection slow Alzheimer's? new trial underway
Disease control OngoingThis Phase 2 study tests an experimental drug called BIIB080 in people with mild cognitive impairment or mild dementia due to Alzheimer's disease. The drug is injected into the fluid around the spinal cord every 12 or 24 weeks. Researchers want to see if it can slow the worsening…
Phase: PHASE2 • Sponsor: Biogen • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Can a phone app help curb heavy drinking? new study tests telehealth approach
Disease control OngoingThis study tests a telehealth program called the Ria Treatment Platform for people with alcohol use disorder. Participants receive medication, coaching, educational videos, and a Bluetooth breathalyzer through their phone. The goal is to see if this approach helps reduce heavy dr…
Phase: NA • Sponsor: Ria Health • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New drug combo aims to tackle bipolar depression and suicidal thoughts
Disease control NO_LONGER_AVAILABLEThis study offers NRX-101, a combination of two drugs, to adults aged 18-65 with treatment-resistant bipolar depression and suicidal thoughts. Participants receive the medication from their own psychiatrist and undergo regular check-ins on mood, suicidal ideation, and side effect…
Sponsor: NeuroRx, Inc. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New drug aims to tackle rare brain disease
Disease control OngoingThis early-stage trial tests a single injection of ARO-ATXN2 in 36 adults with spinocerebellar ataxia type 2, a rare genetic disorder that affects movement and coordination. The main goal is to see if the drug is safe and how the body processes it. Participants are randomly assig…
Phase: PHASE1 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Texting program aims to help smokers with HIV kick the habit
Disease control ENROLLING_BY_INVITATIONThis study tests whether personalized text messages can motivate people living with HIV in Vietnam to quit smoking. Participants receive motivational texts over six months and are encouraged to use a free government quitline that provides nicotine patches. The goal is to see if t…
Phase: NA • Sponsor: University of Massachusetts, Worcester • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Could a fitbit and phone coaching help women with depression stay sober?
Disease control OngoingThis study tests whether a lifestyle physical activity program, supported by a Fitbit and phone counseling, can help women with depression who are in alcohol treatment reduce their risk of relapse. Participants are randomly assigned to either receive the full program or just a Fi…
Phase: NA • Sponsor: Butler Hospital • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Could checking in on symptoms each session boost therapy outcomes?
Disease control OngoingThis study tests whether measurement-based care — where therapists regularly track symptoms using questionnaires — adds extra benefit to weekly psychotherapy for adults with depression or anxiety. Participants are randomly assigned to measurement-based care, standard therapy, or …
Phase: NA • Sponsor: Carilion Clinic • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New program aims to help american indians quit smoking
Disease control OngoingThis study tests a smoking cessation program called All Nations Breath of Life, designed specifically for American Indian communities. It involves 576 participants at four sites—two on reservations and two in urban areas. The program includes counseling and support, and success i…
Phase: NA • Sponsor: Lehigh University • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
ER opioid overdose study pulled before it began
Disease control TerminatedThis pilot study aimed to help people who had an opioid overdose by starting them on buprenorphine/naloxone in the emergency room and then connecting them to an addiction clinic. The goal was to reduce repeat overdoses and improve treatment engagement. However, the study was with…
Sponsor: Nassima Ait-Daoud Tiouririne • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Promising PTSD drug moves to Long-Term safety study
Disease control ENROLLING_BY_INVITATIONThis study is testing the long-term safety and effectiveness of a drug called TSND-201 for adults with PTSD. Participants who completed an earlier blinded trial of TSND-201 can receive up to three treatment courses over 48 weeks, each consisting of four weekly doses. The goal is …
Phase: PHASE3 • Sponsor: Transcend Therapeutics • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Could a diabetes drug curb alcohol cravings? new trial investigates
Disease control OngoingThis phase 2 trial tests whether mazdutide, a drug given as a shot, can help people with alcohol use disorder drink less. About 308 participants will receive either mazdutide or a placebo for up to 36 weeks. The study measures changes in drinking behaviors using a standard questi…
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Cash for clean tests: App-Based rewards tested in older drug users
Disease control OngoingThis study tests whether an app that gives financial rewards for drug-negative saliva tests works for older adults with opioid, cocaine, or methamphetamine use disorder. Researchers will compare results between older and younger participants to see if age affects how well the app…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Phone-Based program aims to help american indians quit smoking
Disease control OngoingThis study tests a telephone-based version of the All Nations Breath of Life program, designed specifically for American Indians who smoke. Participants receive coaching calls over the phone and are compared to those in a general smoking cessation program. The main goal is to see…
Phase: NA • Sponsor: Lehigh University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Put your money where your drink is: study tests deposit contracts to curb heavy drinking
Disease control TerminatedThis study aimed to see if asking people to put down a deposit (between $30 and $100) that they could earn back by meeting their drinking goals would help them drink less. Participants would wear a remote alcohol monitor to track their drinking. The study was withdrawn before any…
Phase: NA • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Keto diet shows promise for bipolar disorder in early trial
Disease control ENROLLING_BY_INVITATIONThis 12-week study is for people who completed a previous trial of the ketogenic diet for first-episode bipolar disorder. Researchers want to see if the diet can improve symptoms like depression, mania, and psychosis, as well as brain energy metabolism and insulin resistance. Abo…
Phase: NA • Sponsor: Mclean Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New drug could slow rare brain disease that steals balance
Disease control OngoingThis phase 3 trial tests whether the drug troriluzole can slow the progression of spinocerebellar ataxia, a rare genetic disorder that affects coordination and balance. About 300 adults with different types of SCA are randomly assigned to take either troriluzole or a placebo dail…
Phase: PHASE3 • Sponsor: Biohaven Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Early rehab after heart attack may save lives and cut hospital visits
Disease control OngoingThis study looks at whether starting a cardiac rehabilitation programme soon after leaving the hospital helps people with coronary artery disease live longer and avoid hospital stays for heart problems. The programme includes counseling, education, and exercise sessions three tim…
Phase: NA • Sponsor: Haukeland University Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New hope for breaking the cycle of domestic violence?
Disease control ENROLLING_BY_INVITATIONThis study tests whether a trauma-informed program called Strength at Home works better than the usual state-approved program for reducing intimate partner violence. About 800 men who are court-ordered to attend such programs, along with their partners, will take part. Researcher…
Phase: NA • Sponsor: Boston University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Brain Radio' trial hopes to crack code of depression treatment
Disease control OngoingThis study tests a special deep brain stimulation (DBS) device that can both stimulate and record brain activity in people with treatment-resistant depression. Ten participants will have electrodes implanted in a brain region called the subcallosal cingulate. The goal is to ident…
Phase: NA • Sponsor: Helen Mayberg, MD • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Can we help people safely stop opioid addiction meds? major study tests new strategies
Disease control OngoingThis study tests different medication and counseling combinations to improve how long people stay in treatment for opioid use disorder and whether they can safely stop medication without relapsing. Over 1,500 participants choose either buprenorphine or naltrexone and are randomly…
Phase: PHASE2 • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Zapping the brain to beat opioid relapse: new study tests Non-Invasive technique
Disease control OngoingThis study tests a new approach to help people recovering from opioid use disorder avoid relapse. About 90% of people in treatment relapse within a year. Researchers will use a gentle, non-invasive brain stimulation method called tDCS combined with cognitive training to see if it…
Phase: NA • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Can targeted addiction care prevent alcohol relapse after liver transplant?
Disease control OngoingThis study tests whether a personalized addiction monitoring program helps liver transplant patients avoid serious alcohol relapse one year after surgery. Researchers will follow 64 adults who are being evaluated for a liver transplant at a French hospital. The program includes m…
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Could a diabetes drug boost antidepressants for weight and mood?
Disease control OngoingThis study tests whether adding the diabetes drug metformin to standard antidepressants helps people with both depression and obesity lose weight and feel better. Researchers will also check if certain gene variants affect how well the combination works. The trial involves 200 ad…
Phase: NA • Sponsor: Riphah International University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Stem cell infusion aims to buy time for kids with fatal brain disease
Disease control TerminatedThis early-stage trial tests whether a single infusion of donated mesenchymal stem cells is safe for children with cerebral adrenoleukodystrophy (cALD), a rare and life-threatening brain disease. The stem cells are given as a temporary bridge to buy time before a more definitive …
Phase: PHASE1 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New dosing strategy aims to make Alzheimer's drug safer and more effective
Disease control OngoingThis study tests different dosing schedules of the drug donanemab in about 1,175 people with early symptomatic Alzheimer's disease. The goal is to find a regimen that lowers brain amyloid plaques while reducing the risk of a side effect called ARIA-E (brain swelling or small blee…
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a blood pressure drug combo tame panic attacks?
Disease control TerminatedThis phase 2 trial tests a new drug called HB-1, which combines two blood pressure medicines (telmisartan and verapamil), to see if it can reduce unexpected panic attacks in people with panic disorder. The study plans to enroll 240 adults aged 18 to 65 and compare HB-1 against pl…
Phase: PHASE2 • Sponsor: HB BioTech, LLC • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Jail-Based PTSD therapy could curb overdose deaths after release
Disease control ENROLLING_BY_INVITATIONThis study tests whether offering PTSD therapy to people in jail who also have opioid or stimulant use disorder can help them start addiction treatment after release. Researchers will screen and refer participants, then randomly assign some to start therapy immediately in jail an…
Phase: NA • Sponsor: University of Arkansas • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a VR avatar help you stay sober? new study investigates
Disease control OngoingThis study tests whether a virtual reality experience, where people see an avatar that looks like them in a park, can help those in early recovery from stimulant use reduce drug use and stay abstinent longer. Researchers will compare this VR experience to a plain VR park without …
Phase: NA • Sponsor: Indiana University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a common MS drug help people with a rare nerve disease walk better?
Disease control OngoingThis clinical trial is testing whether dimethyl fumarate, a drug already used for multiple sclerosis, can improve balance and walking in adults with adrenomyeloneuropathy (AMN), a rare nerve disease. Forty participants will take either the drug or a placebo daily for 36 months, w…
Phase: PHASE2, PHASE3 • Sponsor: Pujol, Aurora, M.D. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a hormone drug slow Alzheimer's? LUCINDA trial tests idea
Disease control OngoingThis phase 2 trial tests whether leuprolide (Eligard), a drug that lowers certain hormones, can slow memory and thinking decline in 180 women with mild Alzheimer's or mild cognitive impairment. All participants are already taking donepezil. The study compares leuprolide injection…
Phase: PHASE2 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New Alzheimer's drug aims to clear brain plaques
Disease control OngoingThis study tests an experimental drug called RO7126209 (Trontinemab) in people with early to moderate Alzheimer's disease. The drug is given by IV infusion and aims to reduce amyloid plaques in the brain, a hallmark of Alzheimer's. About 241 participants will receive either the d…
Phase: PHASE1, PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for depressed smokers: therapy plus quit support shows promise
Disease control OngoingThis study tested whether adding a special type of talk therapy (CBASP) to standard smoking cessation treatment helps depressed smokers quit and feel better. About 91 adults with depression who smoked at least 5 cigarettes a day took part. The goal was to see if the combined appr…
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
App aims to keep HIV patients with addiction on track
Disease control OngoingThis study tests a mobile app called Connections for people living with HIV who also have substance use disorders. The app provides resources, weekly check-ins, discussion rooms, and private messaging with peer mentors and care teams. Researchers want to see if using the app help…
Phase: NA • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Gene therapy trial aims to help girls with rett syndrome gain new skills
Disease control OngoingThis study tests a gene therapy called NGN-401 in 33 girls with Rett syndrome, a rare genetic disorder that affects development and movement. The therapy delivers a working copy of the MECP2 gene to try to improve skills and daily function. Researchers will measure success by whe…
Phase: PHASE3 • Sponsor: Neurogene Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Could an HIV drug help treat rett syndrome?
Disease control ENROLLING_BY_INVITATIONThis phase 2 trial tests whether lamivudine, an antiviral drug, can improve symptoms in people with Rett syndrome, a rare genetic disorder that affects movement, communication, and behavior. Ten participants will take the drug by mouth for a set period, and researchers will measu…
Phase: PHASE2 • Sponsor: Maria Denise Fernandes Carvalho de Andrade • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Can a smartphone app tame disruptive behavior in kids?
Disease control OngoingThis study tests whether a mobile app can help parents of children aged 5-8 with disruptive behavior. 324 families will use either a standalone app, a coach-assisted app, or a control app. The goal is to see if digital tools can improve parenting skills and child behavior at a la…
Phase: NA • Sponsor: University of Pittsburgh • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Can talking about stigma help people with HIV and depression?
Disease control ENROLLING_BY_INVITATIONThis pilot study in Malawi tests whether adding stigma-reduction counseling to standard depression treatment helps people living with HIV. Two hundred adults with HIV and depressive symptoms will receive counseling sessions that challenge myths and build coping skills. Researcher…
Phase: NA • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Could a common supplement help teens with alcohol problems?
Disease control OngoingThis study tests whether citicoline, an over-the-counter supplement, can help young people ages 16 to 22 with alcohol use disorder. Over 4 weeks, participants receive either citicoline or a placebo. Researchers measure changes in immune markers, brain chemistry, and thinking skil…
Phase: PHASE2 • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New study aims to boost addiction treatment access in communities hardest hit by opioid overdoses
Disease control OngoingThis study looks at ways to help people of color living in areas with high overdose rates start and continue medication-assisted treatment (MAT) for opioid or alcohol use. Researchers will track how many treatment sessions people attend and whether they stick with their medicatio…
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Could a common drug slow Alzheimer's? new study tests rapamycin
Disease control OngoingThis study tests whether the drug rapamycin is safe and tolerable for older adults with mild memory problems or early Alzheimer's disease. About 40 participants will take rapamycin for 12 months while researchers monitor side effects and changes in memory and thinking. The goal i…
Phase: PHASE2 • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Could a drug slow rare brain disease? new study uses Real-World data to find out
Disease control OngoingThis study looks at whether the drug troriluzole can slow the progression of spinocerebellar ataxia (SCA), a rare genetic disease that affects movement and balance. Researchers will compare 909 patients who took troriluzole for up to three years with similar patients who did not …
Sponsor: Biohaven Therapeutics Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Could a common heart pill curb stress drinking?
Disease control TerminatedThis small pilot study tested whether propranolol, a beta blocker usually used for high blood pressure, can reduce alcohol drinking triggered by stress. Twenty adults with alcohol use disorder were randomly assigned to take propranolol or a placebo for about two weeks, then compl…
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New depression drug tested for long-term safety in 1,000 patients
Disease control OngoingThis study looks at the long-term safety and effectiveness of an experimental drug called NMRA-335140 for people with major depressive disorder. About 1,000 adults who completed earlier studies of this drug will take it for 52 weeks. Researchers will track side effects and change…
Phase: PHASE3 • Sponsor: Neumora Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New program aims to cut overdose risk for women leaving prison
Disease control ENROLLING_BY_INVITATIONThis study tests a trauma-informed program called TRUST for women leaving prison who have a history of substance use and violent victimization. The program includes individual and group sessions to build skills and support recovery. Researchers will measure changes in substance u…
Phase: NA • Sponsor: Michele Staton • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Autism drug trial pulled before it even started
Disease control TerminatedThis study planned to test the drug bumetanide in children aged 5 to 17 with autism of known cause. The goal was to see if it could improve autism symptoms. However, the trial was withdrawn before enrolling any participants, so no new information was gathered.
Phase: PHASE2 • Sponsor: University Hospital, Limoges • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New study aims to help smokers with HIV kick the habit for good
Disease control OngoingThis study tests whether a smoking cessation medication (varenicline) combined with tools to help people stick with treatment can improve quit rates for smokers living with HIV. About 340 participants will be followed for 6 months to see if they stop smoking, confirmed by breath …
Phase: PHASE3 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Phone alerts could boost med adherence in schizophrenia
Disease control OngoingThis study tests whether daily phone reminders can help people with schizophrenia or schizoaffective disorder remember to take their medication. 104 participants will receive repeated cues on their mobile phones for 30 days. The goal is to see if this improves medication adherenc…
Phase: NA • Sponsor: University of Pittsburgh • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Finger-Prick test could speed up hepatitis c treatment
Disease control OngoingThis study tests whether using a dried blood spot test (a simple finger prick) can help people with hepatitis C start treatment faster than the usual method that requires a blood draw. The trial involves 141 participants who work with a peer support program and telemedicine. The …
Phase: NA • Sponsor: Oregon Health and Science University • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Could ketamine therapy help people quit meth?
Disease control OngoingThis pilot study tests whether combining ketamine injections with talk therapy is a safe and acceptable way to treat moderate-to-severe methamphetamine use disorder in 17 publicly insured patients, some of whom have or are at risk for HIV. Participants receive three monitored ket…
Phase: PHASE2 • Sponsor: Nicky Mehtani, MD, MPH • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Can a new drug stop Alzheimer's before it starts? major trial underway
Disease control OngoingThis study tests an investigational drug called lecanemab in people aged 55-80 who have early signs of Alzheimer's-related brain changes but no memory problems yet. The goal is to see if the drug can slow cognitive decline and reduce amyloid buildup over about 4 years. Around 140…
Phase: PHASE3 • Sponsor: Eisai Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Could a Vitamin-Like pill slow Alzheimer's? new trial seeks answers
Disease control OngoingThis study tests whether benfotiamine, a form of vitamin B1, can safely slow memory and thinking decline in people with early Alzheimer's. About 406 adults aged 50-89 with mild symptoms will take the drug or a placebo for up to 72 weeks. Researchers will measure changes in cognit…
Phase: PHASE2 • Sponsor: Alzheimer's Disease Cooperative Study (ADCS) • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Lung nodule diagnosis sparks new push to help veterans quit smoking
Disease control OngoingThis study tests whether a personalized letter and proactive phone calls can help veterans with a newly diagnosed lung nodule quit smoking. The program uses the diagnosis as a 'teachable moment' to motivate quitting. Researchers will compare how many veterans use cessation servic…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Can a second injection fix penile curvature?
Disease control OngoingThis study tests whether a drug called Xiaflex (collagenase clostridium histolyticum) is safe and effective for men with Peyronie's disease who have already tried platelet-rich plasma (PRP) injections. Twelve men with stable penile curvature between 30 and 90 degrees will receive…
Phase: PHASE4 • Sponsor: University of Miami • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Brain pacemaker trial targets Tough-to-Treat OCD
Disease control OngoingThis study tests a personalized deep brain stimulation (DBS) approach for people with severe obsessive-compulsive disorder (OCD) that hasn't improved with standard treatments. Ten adults will first undergo brain mapping to find the best stimulation targets, then receive a DBS dev…
Phase: NA • Sponsor: Andrew Moses Lee, MD, PhD • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Alzheimer's vaccine trial aims to stop brain protein buildup
Disease control OngoingThis phase 2 study tests a vaccine called JNJ-64042056 in 55 people with very early signs of Alzheimer's (no symptoms yet but tau buildup in the brain). The vaccine is designed to train the immune system to attack tau protein, which forms tangles in Alzheimer's. Participants rece…
Phase: PHASE2 • Sponsor: Janssen Pharmaceutica N.V., Belgium • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New program aims to curb drug use in rural parents by tackling social needs
Disease control OngoingThis study tests a program called Just Care for Families, designed to help parents in rural Oregon who are involved with child welfare services and struggle with opioid or methamphetamine use. The program combines substance use treatment, mental health support, parenting training…
Phase: NA • Sponsor: Chestnut Health Systems • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Hearing aids may slow memory loss in seniors, major trial hopes
Disease control OngoingThis study follows 629 older adults for 3 years to see if using hearing aids and getting hearing rehab can slow down memory loss and lower the risk of dementia. Participants were already in an earlier trial and now continue with hearing care or a delayed treatment. The goal is to…
Phase: PHASE3 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New combo pill tested for long-term safety in teens with mental health conditions
Disease control ENROLLING_BY_INVITATIONThis study is testing the long-term safety of a daily pill called OLZ/SAM (olanzapine plus samidorphan) in 236 teenagers with schizophrenia or bipolar I disorder. Participants have already completed a previous study with the same drug. The goal is to see if the drug is safe and t…
Phase: PHASE3 • Sponsor: Alkermes, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New Nurse-Led telemonitoring program aims to keep seniors with multiple health issues out of the hospital
Disease control OngoingThis study tests a nurse-led program that uses home monitoring devices to help older adults with conditions like heart failure, diabetes, and depression manage their health after leaving the hospital. The goal is to improve care coordination and reduce hospital readmissions. Abou…
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Pistachio power: daily nut snack may boost brain and heart in seniors
Disease control OngoingThis study looks at whether adding pistachios to the daily diet for 6 months can improve memory, thinking speed, and other brain functions in adults aged 65 to 80. It also checks for changes in blood pressure and overall life satisfaction. About 97 participants who are already in…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Mentoring dads: a new way to stop violence and boost child development?
Disease control OngoingThis study tests a program called REAL Fathers in Uganda, where respected community men mentor young fathers (ages 16-25) on positive parenting, conflict resolution, and family planning. Over 4,700 participants are involved. The goal is to see if this approach reduces intimate pa…
Phase: NA • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Gut feeling: personalized bacteria may ease PTSD symptoms
Disease control OngoingThis study looks at whether giving people with PTSD a personalized mix of gut bacteria (called pharmabiotics) can help their mental health. The researchers will track changes in PTSD symptoms, anxiety, depression, and thinking skills over 14 days. The goal is to see if fixing the…
Phase: NA • Sponsor: Uzhhorod National University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug shows promise for Long-Term bipolar depression control
Disease control ENROLLING_BY_INVITATIONThis Phase 3 study tests the long-term safety and effectiveness of azetukalner, a daily pill, in 400 adults with bipolar I or II depression who previously completed a related study. Participants take the drug for 52 weeks, and researchers track side effects, mood changes, and qua…
Phase: PHASE3 • Sponsor: Xenon Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Ketamine may shield patients from PTSD after critical care
Disease control ENROLLING_BY_INVITATIONThis study follows about 1,756 adults who were part of a larger trial and received either ketamine or etomidate during emergency intubation. Researchers want to see if ketamine can reduce PTSD symptoms one year later, since it may block the brain's formation of traumatic memories…
Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Experimental Alzheimer's drug aims to lower brain 'Tangles' in Early-Stage patients
Disease control OngoingThis early-stage trial tests a drug called NIO752 in 38 people with mild Alzheimer's or mild cognitive impairment due to Alzheimer's. The drug is given as one or two injections into the spinal fluid to see if it can lower levels of tau protein, a key marker of Alzheimer's damage.…
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Nudge study aims to help HIV smokers quit
Disease control OngoingThis study looks at whether sending reminders (nudges) to doctors, patients, or both can increase the number of people with HIV who smoke getting help to quit. About 500 patients and their doctors are involved. The goal is to see if these nudges lead to more referrals and partici…
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could a new drug slow Alzheimer's? large trial underway
Disease control OngoingThis phase 3 study tests whether donanemab, an antibody given through an IV, can safely slow cognitive decline in 1500 people with early Alzheimer's. Participants receive either the drug or a placebo for up to 93 weeks. The main goal is to measure changes in thinking and daily fu…
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could an asthma drug curb alcohol cravings? new trial investigates.
Disease control OngoingThis study tests whether ibudilast, an anti-inflammatory drug used in Japan, can help people with alcohol use disorder drink less. Fifty adults will take either ibudilast or a placebo for 6 weeks, plus counseling. The main goal is to see if it reduces the number of heavy drinking…
Phase: PHASE2 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New depression drug tested for Long-Term safety and effectiveness
Disease control ENROLLING_BY_INVITATIONThis study looks at the long-term safety and effectiveness of azetukalner in adults with major depressive disorder. Participants must have successfully completed a previous phase 3 study of this drug. The goal is to monitor side effects and track changes in depression symptoms ov…
Phase: PHASE3 • Sponsor: Xenon Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can a peer coach help you beat opioid addiction? small trial aims to find out
Disease control ENROLLING_BY_INVITATIONThis study tests whether adding peer recovery support—coaching from someone who has personally overcome opioid addiction—to standard medication treatment (buprenorphine) helps people stay in care longer. Fifteen adults with opioid use disorder will receive peer support for 180 da…
Phase: NA • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can a common alcoholism drug help slow ALS? new trial begins
Disease control OngoingThis early-stage study tests the safety of acamprosate, a drug used for alcohol dependence, in 30 adults with ALS who have a specific mutation in the C9orf72 gene. Participants take the pill three times daily for 24 weeks and undergo regular checkups, breathing tests, and spinal …
Phase: PHASE1 • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Hope for lewy body dementia psychosis: new drug enters final testing phase
Disease control ENROLLING_BY_INVITATIONThis study tests a drug called ACP-204 for treating psychosis (hallucinations or delusions) in people with Lewy body dementia. It is a 52-week open-label extension, meaning all 126 participants will receive the drug. The main goal is to check for side effects over the long term. …
Phase: PHASE3 • Sponsor: ACADIA Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Getting kids moving in the ICU could speed recovery, new study suggests
Disease control OngoingThis study tests a program called PICU Up! that helps critically ill children in the intensive care unit start moving earlier than usual. The program combines sleep support, delirium prevention, and less sedation to encourage safe mobility. Researchers will see if this approach r…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Could a common seizure drug help schizophrenia patients lose weight and feel better?
Disease control OngoingThis study looks at whether adding topiramate (a seizure medication) to clozapine can help with weight loss and improve symptoms in people with treatment-resistant schizophrenia or schizoaffective disorder. About 50 overweight or obese adults aged 17-59 who are already on clozapi…
Phase: NA • Sponsor: Centre for Addiction and Mental Health • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Experimental drug zervimesine made available to patients with lewy body dementia
Disease control NO_LONGER_AVAILABLEThis expanded access program offers the experimental drug zervimesine (CT1812) to people aged 50 to 86 with mild-to-moderate dementia with Lewy bodies. Participants take one 100 mg pill daily for up to a year. The goal is to provide access to the drug and collect long-term safety…
Sponsor: Cognition Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
One-shot gene therapy aims to tame rett syndrome in young girls
Disease control OngoingThis early-phase trial tests a single injection of AAV-MECP2 gene therapy into the spinal fluid of 8 girls aged 4-10 with Rett syndrome, a severe neurodevelopmental disorder. The goal is to see if the treatment is safe and can reduce disease severity. The study is not yet recruit…
Phase: EARLY_PHASE1 • Sponsor: Guangzhou Women and Children's Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Can a smartphone app help curb teen aggression? new study says maybe.
Disease control OngoingThis study compares a new blended therapy (online sessions plus in-person visits) to standard in-person therapy for teens with conduct disorder or antisocial behavior. Researchers want to see if the blended approach works just as well at reducing aggression, delinquency, and out-…
Phase: NA • Sponsor: Utrecht University • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New program aims to keep hospital patients on track for opioid and meth recovery
Disease control OngoingThis study tests a program called MIAPP that adds a patient navigator, smartphone check-ins, and small rewards to usual care for people who start buprenorphine for opioid use in the hospital and also use methamphetamine. The goal is to help them connect to outpatient treatment wi…
Phase: NA • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Could a diabetes drug help schizophrenia patients lose weight?
Disease control OngoingThis study tests whether semaglutide, a drug used for diabetes and weight loss, can help people with schizophrenia who are overweight or obese and did not lose weight on metformin. About 92 participants will receive either semaglutide or a placebo. The main goal is to see if sema…
Phase: NA • Sponsor: Centre for Addiction and Mental Health • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Gene therapy could zap Cocaine's high
Disease control OngoingThis early-stage study tests a gene therapy given through an IV for adults with cocaine use disorder who are in remission. The therapy helps the body produce an enzyme that breaks down cocaine quickly, reducing the drug's pleasurable effects. The main goal is to check safety, wit…
Phase: PHASE1 • Sponsor: W. Michael Hooten • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Exercise as medicine: 10-week program targets diabetes and high blood pressure in seniors
Disease control OngoingThis study looks at whether 10 weeks of regular exercise (on land or in water) can lower blood sugar and blood pressure in people aged 60 and older who have several health conditions like diabetes, high blood pressure, and arthritis. 63 volunteers will be split into two exercise …
Phase: NA • Sponsor: Universidade do Porto • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Hospital alcohol therapy boosts recovery engagement
Disease control OngoingThis study tests whether starting alcohol use disorder treatment while still in the hospital helps people stay in treatment and drink less after they go home. 450 adults with moderate to severe alcohol problems will receive either a brief counseling session alone, or that session…
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New Alzheimer's drug OLX-07010 enters first human safety trial
Disease control OngoingThis Phase 1 study tests the safety of OLX-07010, a drug designed to stop tau proteins from clumping in the brain—a hallmark of Alzheimer's disease. Researchers will give single or multiple doses to 88 healthy adults and elderly volunteers to see how the body handles the drug and…
Phase: PHASE1 • Sponsor: Oligomerix, Inc • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
India study aims to match depression patients to best therapy or drug
Disease control OngoingThis study in India tests two common depression treatments—a talk therapy called the Healthy Activity Program and the antidepressant fluoxetine—in 1,500 adults with moderate to severe depression. The goal is to see which treatment works best for different people and to compare co…
Phase: PHASE3 • Sponsor: Harvard Medical School (HMS and HSDM) • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Could Immune-Boosting drugs treat certain psychosis?
Disease control OngoingThis phase 2 trial tests whether a combination of intravenous immunoglobulin (IVIG) and rituximab can help people with psychosis caused by antibodies attacking the brain. 70 participants with acute psychosis and specific antibodies receive either the immunotherapy or a placebo. T…
Phase: PHASE2 • Sponsor: University of Cambridge • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New therapy aims to help transgender and nonbinary people with alcohol problems
Disease control TerminatedThis study is testing a specially adapted form of talk therapy for transgender and nonbinary people who have alcohol use disorder. The therapy, based on interpersonal psychotherapy, is designed to address unique life experiences that may affect drinking. The study will enroll 30 …
Phase: NA • Sponsor: New York State Psychiatric Institute • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Can a phone app with cash rewards help people beat opioid and cocaine addiction?
Disease control OngoingThis study tests whether a smartphone app can help people who are already on methadone treatment cut down on opioid and cocaine use. The app asks participants to take random drug tests at home and rewards them with money for negative results. Researchers want to see if app users …
Phase: PHASE3 • Sponsor: Friends Research Institute, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Can a smartphone app and a peer call curb heavy drinking in veterans?
Disease control OngoingThis study tests if a mobile app called Stand Down, with or without extra support from a peer specialist over the phone, can help Veterans who drink heavily cut back. About 234 Veterans who screened positive for hazardous drinking and own a smartphone are taking part. The goal is…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Alzheimer's drug trial pulled before it even started
Disease control TerminatedThis study aimed to test a drug called BAC in people with Alzheimer's disease or vascular dementia. The goal was to see if it could improve thinking and memory, and to check for side effects. However, the trial was withdrawn before any participants were enrolled, so no results ar…
Phase: PHASE2 • Sponsor: Botanicure Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New pill aims to slow Alzheimer's before symptoms worsen
Disease control OngoingThis study tests an experimental daily pill (RO7269162) in 256 people who either have brain plaques but no symptoms, or have mild memory problems due to Alzheimer's. Participants take the pill or a placebo for about 1.5 years, with regular check-ups to monitor safety and brain ch…
Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Could buntanetap slow Alzheimer's? major trial underway
Disease control OngoingThis study tests whether a daily pill called buntanetap can help people with early Alzheimer's disease think more clearly and handle daily tasks better. About 760 adults aged 55-85 will take either the drug or a placebo for 18 months. Researchers will check memory, thinking, and …
Phase: PHASE3 • Sponsor: Annovis Bio Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Phone app uses GPS to fight opioid relapse
Disease control ENROLLING_BY_INVITATIONThis study tests whether a smartphone app can help people on medication for opioid use disorder stay drug-free. The app tracks location and sends alerts when users enter high-risk areas. Researchers will also use brain scans to understand why some people do better than others. Th…
Phase: NA • Sponsor: University of Arkansas • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Newborn screening study aims to catch rare diseases at birth
Diagnosis OngoingThis study offers voluntary screening for newborns in North Carolina to detect a wide range of rare health conditions early. Using a small blood sample already collected at birth, the program tests for dozens of disorders, including spinal muscular atrophy, cystic fibrosis, and m…
Sponsor: RTI International • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC
-
Brain scans track Alzheimer's clues over decades
Diagnosis ENROLLING_BY_INVITATIONThis study uses special brain scans (PET imaging) to measure amyloid buildup—a protein linked to Alzheimer's—in healthy older adults, people with mild memory problems, and those with dementia. Participants receive scans every 2-3 years for up to 20 years to see how amyloid change…
Phase: PHASE4 • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 14:03 UTC
-
IPad test could revolutionize dementia detection in underserved communities
Diagnosis OngoingThis large study tests whether a simple iPad-based cognitive test, called MyCog, can help primary care doctors detect early dementia and cognitive impairment in underserved communities. Over 57,000 older adults from 24 clinics will take the test during routine visits. The goal is…
Phase: NA • Sponsor: Northwestern University • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC
-
A simple taste test could revolutionize depression treatment
Diagnosis TerminatedThis study explores whether a taste test can serve as a diagnostic tool for depression. Participants with untreated major depressive disorder will take a taste test before and after starting an antidepressant prescribed by their doctor, and again six to eight weeks later. The goa…
Phase: NA • Sponsor: Ranvier Health Ltd • Aim: Diagnosis
Last updated Jun 27, 2026 14:01 UTC
-
New turkish questionnaire could help belgian GPs spot hidden depression
Diagnosis ENROLLING_BY_INVITATIONThis study tests whether a Turkish translation of the Four-Dimensional Symptom Questionnaire (4DSQ) helps Belgian general practitioners who don't speak Turkish better diagnose depression and anxiety in Turkish-speaking patients with language barriers. About 80 patients and their …
Phase: NA • Sponsor: Universitair Ziekenhuis Brussel • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
Bladder ultrasound may predict treatment success in kids with bedwetting
Diagnosis OngoingThis study looks at whether measuring bladder wall thickness with an ultrasound can help predict treatment response in children aged 5-17 with lower urinary tract problems or bedwetting. Researchers will compare bladder wall measurements between the two groups and see if thicknes…
Sponsor: Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
Could a simple tablet test and AI catch dementia years earlier?
Diagnosis ENROLLING_BY_INVITATIONThis study explores whether a self-administered digital test called eSAGE, combined with information from electronic health records and machine learning, can help detect early signs of cognitive impairment, including dementia and Alzheimer's disease. Researchers will analyze data…
Sponsor: Douglas Scharre • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
New PET tracer aims to spot Alzheimer's plaques safely
Diagnosis OngoingThis study tests a new radioactive tracer called Fluselenamyl for PET scans to detect beta-amyloid plaques in the brain, a hallmark of Alzheimer's disease. Researchers will check its safety and how well it works in 60 healthy volunteers and people with mild cognitive impairment o…
Sponsor: Washington University School of Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 13:05 UTC
-
New brain scan aims to spot Alzheimer's before symptoms worsen
Diagnosis TerminatedThis study aimed to see if a special fMRI scan (fMRI-SAM) could help detect Alzheimer's disease early. Researchers planned to compare brain activity in 25 people with Alzheimer's, 25 with mild memory problems (MCI), and 60 healthy adults. The goal was to find differences that mig…
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Diagnosis
Last updated Jun 27, 2026 13:05 UTC
-
AI spots hidden liver disease in routine scans
Diagnosis ENROLLING_BY_INVITATIONThis study tests whether an AI system can help doctors identify patients with fatty liver disease who need specialist care. About 8,000 adults getting routine CT scans will have their images analyzed by AI to flag those at risk. The goal is to see if AI can improve detection and …
Phase: NA • Sponsor: Shengjing Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
Could a diabetes drug help detect Alzheimer's early?
Diagnosis OngoingThis early-phase study tests whether a single injection of pramlintide, a diabetes drug, can temporarily increase levels of Alzheimer's-related proteins in the blood, potentially revealing early signs of the disease. Researchers will measure changes in beta-amyloid and tau protei…
Phase: EARLY_PHASE1 • Sponsor: Boston University • Aim: Diagnosis
Last updated Jun 27, 2026 12:38 UTC
-
Super-Sharp brain scanner could revolutionize diagnosis of dementia and cancer
Diagnosis ENROLLING_BY_INVITATIONThis study compares a new ultra-high resolution PET/CT scanner, the NeuroEXPLORER, with standard clinical PET/CT scanners for imaging the head and neck. Researchers aim to see if the new device provides more detailed images to improve diagnosis of conditions like dementia, Parkin…
Phase: NA • Sponsor: prof. dr. Koen Van Laere • Aim: Diagnosis
Last updated Jun 27, 2026 12:36 UTC
-
Can rewards and support keep drug users HIV-Free?
Prevention OngoingThis study tests a 24-week program called CoMPASS that uses rewards (contingency management) and extra support to help people who inject drugs take PrEP consistently for HIV prevention. About 526 participants with opioid use disorder will be enrolled. Those who don't stick with P…
Phase: NA • Sponsor: Yale University • Aim: Prevention
Last updated Jul 04, 2026 00:00 UTC
-
Can a simple screening program stop opioid addiction before it starts?
Prevention OngoingThis study tests a program designed to prevent opioid misuse in people hospitalized for a traumatic injury. Participants complete brief questionnaires about pain and opioid use risk, and receive enhanced care coordination based on their responses. The goal is to see if this adapt…
Phase: NA • Sponsor: University of Wisconsin, Madison • Aim: Prevention
Last updated Jul 03, 2026 00:00 UTC
-
New study aims to boost HIV prevention in vulnerable women
Prevention OngoingThis study tests two counseling programs to help women who use drugs in Tanzania start and stay on PrEP, an HIV prevention pill. 200 women will be randomly assigned to receive either brief motivational counseling, the same plus extra mental health support, or standard information…
Phase: NA • Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Prevention
Last updated Jun 27, 2026 14:02 UTC
-
New online 'Behavioral Vaccine' aims to stop teen depression before it starts
Prevention OngoingThis study tests a self-guided online program called CATCH-IT, designed to prevent depression in teenagers who are at risk. Researchers are working with 400 teens aged 13-18 across four health systems to find the best way to deliver this program in primary care. The goal is to se…
Phase: NA • Sponsor: University of Illinois at Chicago • Aim: Prevention
Last updated Jun 27, 2026 14:01 UTC
-
Can online or group programs stop teen depression before it starts?
Prevention OngoingThis study tests two different programs designed to prevent depression in teenagers who are at risk. One program is an online course called CATCH-IT, and the other is an 8-session group program called TEAMS. About 636 teens aged 13-19 with mild depressive symptoms but no current …
Phase: NA • Sponsor: University of Illinois at Chicago • Aim: Prevention
Last updated Jun 27, 2026 14:01 UTC
-
Breathing in calm: new sedation method may keep ICU patients Clear-Headed
Prevention OngoingThis study compares two ways to sedate ICU patients who need a breathing machine: inhaled sedation (using isoflurane gas) versus standard intravenous (IV) sedation. The goal is to see if the inhaled approach reduces the chance of delirium—a state of confusion that often occurs in…
Phase: PHASE3 • Sponsor: University Hospital, Brest • Aim: Prevention
Last updated Jun 27, 2026 14:00 UTC
-
One-Stop care may boost HIV and hep c treatment in drug users
Prevention OngoingThis study tests whether providing HIV prevention (PrEP) and hepatitis C treatment together at one location works better than sending patients to separate clinics. About 446 people who inject drugs will be randomly assigned to either on-site integrated care or off-site referrals …
Phase: NA • Sponsor: Columbia University • Aim: Prevention
Last updated Jun 27, 2026 14:00 UTC
-
Can a simple 8-Week program keep your brain sharp?
Prevention OngoingThis study tests an 8-week group program called My Healthy Brain for adults aged 50 and older who have memory concerns but not dementia. The program teaches about lifestyle factors like exercise, sleep, and diet that may help prevent dementia. Researchers want to see if the progr…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Prevention
Last updated Jun 27, 2026 14:00 UTC
-
Teen therapy aims to stop bipolar before it starts
Prevention OngoingThis study tests whether a type of talk therapy called Interpersonal and Social Rhythm Therapy (IPSRT) can prevent bipolar disorder in teenagers (ages 12-18) who have a parent with bipolar disorder and are considered high-risk. Participants receive 8 sessions of IPSRT or a health…
Phase: NA • Sponsor: University of Pittsburgh • Aim: Prevention
Last updated Jun 27, 2026 13:06 UTC
-
New program aims to stop postpartum depression before it starts
Prevention OngoingThis study tests a psychological empowerment program designed to prevent postpartum depression in pregnant women. 92 first-time mothers in Indonesia will take part in 5 group sessions over 3 weeks, focusing on control, confidence, and coping. Researchers will check if the program…
Phase: NA • Sponsor: Miranie Safaringga • Aim: Prevention
Last updated Jun 27, 2026 13:05 UTC
-
Could a common diabetes drug ward off Alzheimer's?
Prevention OngoingThis study tests whether metformin, a drug used for diabetes, can prevent Alzheimer's dementia in people with mild cognitive impairment (MCI). Over 18 months, 326 overweight adults aged 55-90 with MCI will receive either metformin or a placebo. Researchers will track memory, brai…
Phase: PHASE2, PHASE3 • Sponsor: Columbia University • Aim: Prevention
Last updated Jun 27, 2026 13:03 UTC
-
Broccoli extract could slash psychosis risk in At-Risk youth
Prevention OngoingThis study tests whether sulforaphane, a compound found in broccoli, can prevent psychosis in 300 people at high risk. Participants take either sulforaphane or a placebo daily for a year, then are followed for another year. The main goal is to see if fewer people in the sulforaph…
Phase: PHASE3 • Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Prevention
Last updated Jun 27, 2026 13:00 UTC
-
Phone-Based group therapy aims to stop postpartum depression before it starts
Prevention OngoingThis study tests a 12-week digital group program called IMAGINE to see if it can prevent depression in pregnant people and new mothers who are at higher risk. About 100 participants will either join the online group or receive standard care. Researchers will check depression and …
Phase: NA • Sponsor: University of Washington • Aim: Prevention
Last updated Jun 27, 2026 12:37 UTC
-
Zapping the Brain's fear center: a new hope for depression?
Symptom relief ENROLLING_BY_INVITATIONThis study tests a non-invasive device that uses gentle electrical currents to stimulate the right amygdala, a brain area linked to emotion. Fifty adults with major depression will receive either real or sham stimulation for six weeks. Researchers will measure changes in mood, th…
Phase: NA • Sponsor: Ruijin Hospital • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Bedtime stories for autism? Single-Child trial shows early gains
Symptom relief OngoingThis study tests whether listening to special audio fairy tales before sleep can improve speech, motor skills, and independence in a child with autism and central auditory processing disorder. The child stays at home with their mother, avoiding clinic stress. Early results from t…
Phase: NA • Sponsor: Natalia Poluektova • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Two brain zaps may lift the fog of Schizophrenia's negative symptoms
Symptom relief ENROLLING_BY_INVITATIONThis trial investigates whether combining two types of brain stimulation—intermittent theta burst stimulation (iTBS) and high-definition transcranial direct current stimulation (HD-tDCS)—can reduce negative symptoms of schizophrenia, such as lack of motivation, social withdrawal,…
Phase: NA • Sponsor: Tri-Service General Hospital (TSGH) • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Book club therapy: could group reading boost language skills after stroke?
Symptom relief OngoingThis study explores whether joining a weekly reading group can improve reading comprehension and communication confidence in adults with aphasia, a language disorder often caused by stroke. Participants read a book at home and then discuss it in a 90-minute group session each wee…
Phase: NA • Sponsor: University of Arkansas • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Could a gentle brain zap help stroke survivors find their words again?
Symptom relief OngoingThis study explores whether adding a non-invasive brain stimulation technique called transcranial direct current stimulation (tDCS) to standard speech therapy can improve word-finding in people with aphasia after a stroke. The trial involves 50 adults who are at least six months …
Phase: NA • Sponsor: University of Arkansas • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Could squeezing a ball make port needle changes less painful?
Symptom relief ENROLLING_BY_INVITATIONThis study investigates whether using a stress ball during port catheter needle changes can reduce pain, anxiety, and improve satisfaction in cancer patients. Fifty adult oncology patients will be randomly assigned to either use a stress ball or receive standard care. The goal is…
Phase: NA • Sponsor: Kahramanmaras Sutcu Imam University • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Restless leg drug tested for rare disease in women
Symptom relief OngoingThis study looks at whether pramipexole, a drug used for restless leg syndrome, can ease leg symptoms in women with X-linked adrenoleukodystrophy (ALD). About 24 women will take the drug or a placebo for two months. The goal is to see if it improves sleep, walking, and quality of…
Phase: PHASE4 • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Sniffing essential oils during surgery may ease anxiety and mask burnt flesh smell
Symptom relief OngoingThis study tests whether smelling essential oils during skin surgery can reduce the unpleasant smell of burnt flesh from electrocautery and lower patient anxiety. About 111 adults having same-day skin procedures will be randomly assigned to receive either a real essential oil inh…
Phase: NA • Sponsor: Northwestern University • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Ancient wisdom meets modern science: new group therapy targets anxiety
Symptom relief OngoingThis study explores whether a new type of group therapy, based on Eastern cultural practices, can help people with anxiety disorders. Researchers will enroll 60 participants aged 15 to 55 to test the therapy's effects on anxiety symptoms. The goal is to see if this approach is bo…
Phase: NA • Sponsor: Beijing HuiLongGuan Hospital • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
New pain block could cut opioid use after back surgery
Symptom relief OngoingThis study tests whether a targeted nerve block (retrolaminar block) provides better pain relief after lumbar discectomy than the standard method of injecting pain medicine into the surgical wound. 130 adults having elective single-level herniated disc surgery will be randomly as…
Phase: NA • Sponsor: Zagazig University • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Can a gentle massage and scent boost appetite in dementia?
Symptom relief ENROLLING_BY_INVITATIONThis study tests a simple, drug-free approach to help people with moderate-to-severe dementia who struggle with eating. The experimental group receives a salivary gland massage combined with aromatherapy before meals for 20 days, while the control group gets a palm massage. Resea…
Phase: NA • Sponsor: National Cheng Kung University • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Can a phone app ease social anxiety? new study investigates
Symptom relief TerminatedThis study tests whether a smartphone app that delivers cognitive behavioral therapy (CBT) can help adults with social anxiety disorder. Participants use the app for 12 weeks, learning skills like cognitive restructuring and exposure exercises. The trial compares app users to a w…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Omega-3s show promise for Tough-to-Treat depression
Symptom relief OngoingThis study looked at whether omega-3 fatty acids can reduce inflammation and improve mood in adults with treatment-resistant depression. Fourteen participants who were already on antidepressants but still depressed were randomly given either omega-3 supplements or a placebo for 1…
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Could matching daily choices cut dementia agitation?
Symptom relief TerminatedThis study tests whether a structured conversation between people with dementia or mild cognitive impairment and their care partners can reduce difficult symptoms like agitation and depression. The idea is that when care partners better understand the person's everyday preference…
Phase: NA • Sponsor: Mclean Hospital • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Fish oil compound tested as autism symptom treatment
Symptom relief OngoingThis study tests whether DHA, a key omega-3 fatty acid found in fish oil, can improve symptoms of autism in children and adolescents aged 5 to 17. Participants receive either DHA or a placebo daily for 12 weeks. Researchers also look at genes and urine markers related to DHA to u…
Phase: NA • Sponsor: Rutgers, The State University of New Jersey • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Horses help heal: new therapy for personality disorder patients
Symptom relief OngoingThis small study will test whether spending time with horses as part of therapy can help inpatients with emotionally unstable personality disorder (EUPD) manage their emotions and feel more connected to others. Six participants will take part in six sessions of equine-assisted ps…
Phase: NA • Sponsor: Cygnet Healthcare • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Can a phone app tame workplace burnout for officers working with troubled youth?
Symptom relief OngoingThis study tests whether a smartphone app called AIM+ can help juvenile justice officers and other professionals who work with youth in the legal system manage chronic stress, anxiety, and burnout. Over 30 days, participants use the app for short guided meditations and videos. Th…
Phase: NA • Sponsor: University of Illinois at Chicago • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
New study tests common antidepressant for PTSD in military and civilian groups
Symptom relief TerminatedThis phase 2 study is testing whether fluoxetine, a widely used antidepressant, can reduce PTSD symptoms in 800 adults including active-duty service members, veterans, and civilians. Participants receive either fluoxetine or a placebo for 12 weeks, and researchers measure changes…
Phase: PHASE2 • Sponsor: Global Coalition for Adaptive Research • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Can an online mindfulness course protect your brain?
Symptom relief OngoingThis study tests whether an 8-week internet-based mindfulness program (iMBSR) can improve brain health in adults aged 50 and older who have subjective cognitive decline, a potential early sign of Alzheimer's disease. Sixty participants will be randomly assigned to either the mind…
Phase: NA • Sponsor: Ohio State University • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Could intense exercise help tame adult ADHD?
Symptom relief ENROLLING_BY_INVITATIONThis study explores whether high-intensity interval training (HIIT) is a practical and acceptable treatment for adults with ADHD. Researchers will recruit 30 adults diagnosed with ADHD to participate in a 14-week exercise program combining strength and endurance training. The goa…
Phase: NA • Sponsor: Solli Distriktspsykiatriske Senter • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
New therapy combo targets deep brain responses in dissociative disorders
Symptom relief ENROLLING_BY_INVITATIONThis pilot study explores whether combining a trauma-focused therapy called Deep Brain Reorienting (DBR) with a supportive group program is feasible and helpful for adults with complex dissociative disorders like Dissociative Identity Disorder. Ten participants will receive weekl…
Phase: NA • Sponsor: Modum Bad • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Online therapy could ease anxiety in autistic teens
Symptom relief OngoingThis study tests an internet-based cognitive behavioral therapy (CBT) program designed to help autistic adolescents aged 11-17 manage anxiety. The program, called LUNA-Adolescent, is parent-led and delivered online, making it easier for families who cannot access in-person therap…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Can virtual reality or a simple schedule change ease kids' fear during pin removal?
Symptom relief ENROLLING_BY_INVITATIONThis study looks at two ways to lower anxiety in children aged 3 to 10 who need surgical pins removed from an elbow fracture. One approach removes the pins right after the cast comes off, before an X-ray, instead of after. The other uses a virtual reality headset during the pin r…
Phase: NA • Sponsor: Boston Children's Hospital • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Could a sleep drug soothe PTSD? new study recruits troops and civilians
Symptom relief TerminatedThis study tests whether daridorexant, a drug used for insomnia, can reduce PTSD symptoms in 200 adults, including active-duty service members, veterans, and civilians. Participants receive either the drug or a placebo for 12 weeks, and researchers track changes in PTSD severity …
Phase: PHASE2 • Sponsor: Global Coalition for Adaptive Research • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Can an online program help health students beat stress?
Symptom relief OngoingThis study tests an 8-week online stress management program for health students in Sfax, Tunisia. The program combines cognitive-behavioral therapy and mindfulness meditation through videos, exercises, and motivational messages. Researchers will measure changes in stress, anxiety…
Phase: NA • Sponsor: University of Sfax • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
New app aims to curb binge eating in overweight teens
Symptom relief OngoingThis study is testing a mobile app designed to help teenagers who struggle with binge eating and are overweight or at risk for obesity. The app uses strategies from cognitive-behavioral therapy to improve self-regulation and eating habits. Fifty teens will use the app for 16 week…
Phase: NA • Sponsor: University of Pittsburgh • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Could quicker brain zaps lift depression faster?
Symptom relief OngoingThis study tests whether an accelerated form of transcranial magnetic stimulation (TMS) can safely and effectively reduce depression symptoms in people with major depressive disorder. About 50 participants aged 15 and older will receive the treatment in an open-label design. The …
Phase: NA • Sponsor: Neuronetics • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Could a nighttime sound machine help fight Alzheimer's?
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether a device that plays brief, soft sounds during deep sleep can enhance brain wave activity in people with mild cognitive impairment due to Alzheimer's disease. Participants use the device at home each night for three months, with an optional three-month ext…
Phase: NA • Sponsor: Bitbrain • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Texts after trauma: new study tests simple tools to prevent PTSD and opioid abuse
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether a short video and a 3-week text messaging program can help people who have recently experienced sexual assault. The goal is to see if these tools can reduce mental health problems like PTSD and prevent misuse of opioids and other substances. About 394 adu…
Phase: NA • Sponsor: University of Wisconsin, Madison • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
New depression pill shows promise in Late-Stage trial
Symptom relief OngoingThis study tests an oral medication called MM120 against a placebo in adults with major depressive disorder. The trial has two parts: a 12-week blinded phase followed by a 40-week open-label extension where everyone gets MM120. The main goal is to see if MM120 reduces depression …
Phase: PHASE3 • Sponsor: Definium Therapeutics US, Inc. • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Shorter PTSD therapy may be just as effective for veterans
Symptom relief OngoingThis study compares a shorter therapy focused on guilt (TrIGR) to a standard PTSD therapy (CPT) in 160 U.S. Veterans. The goal is to see if TrIGR is no less effective at reducing PTSD, depression, and guilt symptoms. Participants are randomly assigned to one of the two treatments…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Could farm animals help young adults with autism break out of social isolation?
Symptom relief OngoingThis trial explores whether spending time on a farm with animals and nature can help socially withdrawn young adults (ages 18–30) with autism spectrum disorder. Participants take part in supervised group activities on a farm twice a week for 12 weeks. Researchers will interview p…
Phase: NA • Sponsor: Kronoberg County Council • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
New web program aims to ease burden for dementia caregivers
Symptom relief ENROLLING_BY_INVITATIONThis study tests a web-based support program called Hospital GamePlan4Care for caregivers of veterans with dementia who are discharged from skilled nursing facilities to home. Fifty-five caregivers will receive either the program (website, emails, and phone coaching) or basic hea…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Can sensory rooms ease Alzheimer's symptoms? new study investigates
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether a special therapy using sights, sounds, touch, and other senses can help people with moderate Alzheimer's think clearer, feel calmer, and behave better. It also looks at whether this therapy reduces stress for their caregivers. Twenty-four people aged 65 …
Phase: NA • Sponsor: Hacettepe University • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Dance moves tested as therapy for Brain-Body disorder
Symptom relief OngoingThis study tests whether a structured dance and movement program is practical and acceptable for people with functional neurological disorder (FND), a condition where the brain doesn't send proper signals to the body. Thirty adults with FND will be randomly assigned to either dan…
Phase: NA • Sponsor: King's College London • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
Can a buddy system boost mental health during hormone therapy?
Symptom relief OngoingThis study looks at whether a peer support program is acceptable and helpful for people with mild depression or anxiety who are starting or receiving hormone care. One hundred participants are randomly assigned to either the peer support group or usual care. The program includes …
Phase: NA • Sponsor: University of Michigan • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
Can talk therapy break the cycle of depressive rumination?
Symptom relief OngoingThis study looks at whether Behavioral Activation (BA) therapy can change the habit of repetitive negative thinking (rumination) in people with major depression. Up to 120 adults will receive 12 sessions of BA over 11 weeks. Researchers will measure symptom changes and explore wh…
Phase: NA • Sponsor: University of Iceland • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
New app aims to ease burden for rural dementia caregivers
Symptom relief OngoingThis pilot study tests a mobile app called Brain CareNotes designed to reduce the burden on unpaid caregivers of people with Alzheimer's or related dementias who live in rural areas. About 60 caregivers will use either the Brain CareNotes app or a basic education app for six mont…
Phase: NA • Sponsor: Richard Holden • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
Can eye contact training help toddlers with autism? new trial tests Parent-Led therapy
Symptom relief OngoingThis study tests whether a parent-led therapy called Pathways can improve social skills in 80 toddlers (16-30 months old) who show early signs of autism. One group of parents learns a technique to encourage mutual eye contact during play, while the other group uses the same thera…
Phase: NA • Sponsor: The University of Texas at Dallas • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
Can a brain ZAP boost thinking skills in severe mental illness?
Symptom relief OngoingThis study tests whether combining cognitive remediation training (a computer-based program to improve thinking skills) with mild brain stimulation (transcranial direct current stimulation) can help people with severe mental illness who live in supported housing. The goal is to i…
Phase: NA • Sponsor: University of Groningen • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
Ear seeds may boost IVF success by calming anxiety
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether a simple ear acupressure technique, called auricular point sticking therapy, can reduce anxiety and improve sleep in women undergoing IVF. 178 women aged 20-45 with anxiety or insomnia will either receive standard IVF care or standard care plus ear acupre…
Phase: NA • Sponsor: Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
New electric therapy aims to treat depression without memory loss
Symptom relief OngoingThis small study tests a new treatment called TEST for people with depression that hasn't improved with standard treatments. TEST uses a lower electric current than standard electroconvulsive therapy (ECT), aiming to avoid memory and thinking problems. Eight adults aged 25-64 wil…
Phase: NA • Sponsor: National Institute of Mental Health (NIMH) • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
Could xenon gas lift depression in hours?
Symptom relief OngoingThis early-phase trial tests whether inhaling a low dose of xenon gas can quickly improve depressive symptoms in 20 people with treatment-resistant major depression or bipolar depression. Participants receive either xenon or a placebo gas added to their usual treatment, and resea…
Phase: EARLY_PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
Virtual reality could calm anxious kids with autism at the dentist
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether wearing a virtual reality (VR) headset during dental treatment can reduce fear and stress in children with mild intellectual disabilities or autism spectrum disorder. Two hundred children aged 6 to 12 will either receive standard dental care or use a VR h…
Phase: NA • Sponsor: Semmelweis University • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Can virtual reality help adults with autism connect better?
Symptom relief OngoingThis study tests a new virtual reality program designed to help adults with autism improve their social skills and daily functioning. 140 participants will either receive the VR training plus usual care, or usual care alone, for 3 months. Researchers will measure changes in socia…
Phase: NA • Sponsor: University Hospital Bispebjerg and Frederiksberg • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Online classes before birth may shield new moms from PTSD
Symptom relief OngoingThis study tests whether giving first-time mothers online education about childbirth starting at 30 weeks of pregnancy can lower their risk of post-traumatic stress after delivery. Researchers will enroll 400 women and track their mental health through surveys at 6 weeks and 6 mo…
Phase: NA • Sponsor: University of California, San Diego • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
New therapy approach aims to keep minority teens in mental health care
Symptom relief ENROLLING_BY_INVITATIONThis study tests a new method called Strategic Treatment Assessment for Youth (STAY) designed to help racial and ethnic minority teens with depression or suicidal thoughts stay in therapy. Researchers will compare STAY to standard care in 140 teens aged 12-18 across three communi…
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Can a massage at home ease painful sex? new study tests telehealth approach
Symptom relief OngoingThis study tests whether a pelvic floor massage technique (Thiele massage) can reduce pain during sex in women with chronic pelvic pain. It compares in-person treatment with guided self-massage at home via telehealth. The goal is to see if telehealth can be as effective as in-per…
Phase: NA • Sponsor: University of Sao Paulo • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Magic mushroom compound tested for PTSD relief in small study
Symptom relief OngoingThis early-stage study tests whether psilocybin (the active ingredient in magic mushrooms) can safely help adults with long-term PTSD who are already taking antidepressants. Twenty participants will receive psilocybin, and some will also get trauma-focused talk therapy. The goal …
Phase: PHASE1 • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
New anxiety pill shows promise in major trial
Symptom relief OngoingThis study tests an oral medication called MM120 against a placebo in 245 adults with generalized anxiety disorder. Participants take the drug or placebo for 12 weeks, and those who complete may join a 40-week follow-up where everyone gets the active drug. The goal is to see if M…
Phase: PHASE3 • Sponsor: Definium Therapeutics US, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Can a 10-week online program help people with depression and schizophrenia get out more?
Symptom relief OngoingThis study tests a behavioral program called SWITCH that teaches people with serious mental illness (like depression, schizophrenia, or bipolar disorder) to set goals, use rewards, and build habits to do more activities outside the home. 52 participants will attend weekly online …
Phase: NA • Sponsor: Temple University • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
New anxiety pill shows promise in Late-Stage trial
Symptom relief OngoingThis phase 3 study tests whether an oral medication called MM120 can reduce anxiety symptoms in adults with generalized anxiety disorder. About 214 participants will receive either MM120 or a placebo for 12 weeks, followed by a 40-week period where everyone can receive MM120. The…
Phase: PHASE3 • Sponsor: Definium Therapeutics US, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Could a zapping cap help Alzheimer's patients remember?
Symptom relief OngoingThis study tests whether a safe, painless brain stimulation technique called tDCS can improve verbal learning in people with Alzheimer's disease. Researchers will compare active stimulation to a sham (fake) version in 90 participants with typical or language-based Alzheimer's. Th…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Sugar water injection may ease PTSD symptoms
Symptom relief OngoingThis study tests whether injecting a dextrose (sugar water) solution around nerves in the neck can reduce PTSD symptoms like anxiety and brain fog. Twenty-four adults who have tried at least two medications and two non-drug treatments for PTSD will receive either the injection or…
Phase: NA • Sponsor: Dr. Dean Reeves Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
One therapy to tackle both anxiety and drinking in veterans?
Symptom relief OngoingThis study tests a single cognitive behavioral therapy (CBT) program designed to help veterans who struggle with both anxiety (including PTSD) and hazardous drinking. The goal is to see if treating both issues together improves their daily functioning and reduces symptoms better …
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Light therapy wearables could ease Alzheimer's sleep troubles
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether a wearable light device can help improve sleep and daily rhythms in people with Alzheimer's who have sleep problems. Researchers will also use activity trackers and blood tests to better understand the disease. About 162 participants will try the light th…
Phase: NA • Sponsor: China Medical University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Brain and body boost: Dual-Task training may ease Parkinson's symptoms
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether adding cognitive training to balance and gait exercises helps people with Parkinson's disease improve their balance, walking, and thinking. Fourteen participants will undergo 12 sessions of combined training. The goal is to see if this approach eases move…
Phase: NA • Sponsor: Gazi University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Ancient chinese music tunes tested as depression treatment
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether a unique music therapy, based on Traditional Chinese Medicine's five-element theory, can help men with depression and anxiety when added to their usual medication. One hundred male inpatients will receive either standard drugs alone, drugs plus regular mu…
Phase: NA • Sponsor: University of Malaya • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Light at the end of the tunnel? wearable device aims to lift elderly depression
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether a wearable headband that shines near-infrared light can improve depression and sleep in adults aged 60 and older with major depression. Participants will wear the device for up to 8 weeks, and researchers will track sleep, mood, and daily activity using a…
Phase: NA • Sponsor: China Medical University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New study aims to bring autism therapy to more kids through public system
Symptom relief OngoingThis study tests whether training early intervention providers in Reciprocal Imitation Training can help children with autism improve imitation and communication skills. The program involves 440 children and their caregivers, with providers learning simple strategies during play.…
Phase: NA • Sponsor: University of Washington • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Can a One-Size-Fits-All therapy help depression and anxiety?
Symptom relief TerminatedThis study was designed to test whether a group therapy that uses basic communication skills common to all therapies can help people with depression, anxiety, PTSD, and stress. The therapy avoids specific methods like cognitive-behavioral therapy. The trial was withdrawn before a…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Could a week of ketamine pills speed up depression relief?
Symptom relief OngoingThis study tests whether adding ketamine tablets to a new antidepressant can reduce depression symptoms faster in adults with major depression. Twelve participants will take four doses of ketamine over one week while starting a standard antidepressant. The goal is to see if sympt…
Phase: PHASE2 • Sponsor: Daniel Lindqvist • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Toys and gadgets may take the ouch out of Kids' blood tests
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether simple distraction tools—a ShotBlocker device and a finger puppet—can reduce pain and fear in children aged 5 to 10 during blood draws. About 90 children will be randomly assigned to use one of these tools or receive standard care. The goal is to see if t…
Phase: NA • Sponsor: Abant Izzet Baysal University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Music on autopilot: could it calm Alzheimer's agitation?
Symptom relief TerminatedThis study planned to test whether automated music therapy could help manage agitation and sleep problems in people with severe Alzheimer's living in nursing homes. An actigraph would detect sleep issues and trigger music sessions automatically. The trial was withdrawn before any…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New program gets depressed teens moving again
Symptom relief ENROLLING_BY_INVITATIONThis study tests a new program called BRIDGES, designed with teens, to help young people with depression become more active at their own pace. The goal is to see if increasing physical activity can reduce depressive symptoms. The study will involve 60 adolescents aged 12-19 who a…
Phase: NA • Sponsor: Université Catholique de Louvain • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New study aims to ease agitated delirium in dying cancer patients
Symptom relief OngoingThis study looks at how well two drugs, haloperidol and lorazepam, can control severe agitation and confusion (delirium) in people with advanced cancer who are in palliative care. About 110 patients will be enrolled to compare different drug approaches. The goal is to improve com…
Phase: PHASE2, PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Serious games tested as Cost-Effective therapy for Alzheimer's
Symptom relief OngoingThis study looks at whether special video games (serious games) that combine physical and mental exercises are a good value for managing Alzheimer's disease. About 136 people with mild to moderate Alzheimer's will either play these games with a therapist or receive usual care. Re…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Online depression program for orthopedic patients pulled before starting
Symptom relief TerminatedThis study aimed to see if a web-based self-help program called Deprexis could help orthopedic patients with major depressive disorder. The plan was to offer the 8-week online program to patients with depression and see if they would use it and if their mood and physical function…
Phase: NA • Sponsor: Jasper A. Smits • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New app aims to ease cancer symptoms for rural patients
Symptom relief TerminatedThis study tests a telemedicine program called FOCUS that helps advanced cancer patients manage common symptoms like trouble sleeping, worry, tiredness, and low mood. The program uses counseling techniques delivered through a phone app. Researchers will enroll 120 adults with adv…
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Can brain training beat Schizophrenia's 'Negative' symptoms?
Symptom relief OngoingThis study tests two 18-month talk therapy programs—Cognitive Enhancement Therapy and Enriched Supportive Therapy—for people with schizophrenia who have lasting negative symptoms like low motivation and social withdrawal. About 90 outpatients aged 18-60 will participate. The goal…
Phase: NA • Sponsor: University of Pittsburgh • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Mind over mood: new brain training targets Depression's repetitive thoughts
Symptom relief TerminatedThis study tests whether real-time brain scans (fMRI) can help people with depression learn to reduce rumination—repetitive negative thinking. 80 participants will receive either real or sham neurofeedback while in a powerful 7T MRI machine. The goal is to strengthen a specific b…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Phone-Based therapy may lift mood in expectant moms
Symptom relief OngoingThis study tests whether a digital cognitive behavioral therapy program, supported by telephone coaching, can help reduce depression symptoms in pregnant women. About 634 mothers with mild to moderate depression were randomly assigned to either the guided digital program or stand…
Phase: NA • Sponsor: University of Turku • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New study tests At-Home programs to ease pain and anxiety after cancer surgery
Symptom relief OngoingThis study compares two different remote support programs to see which one helps women feel better after surgery for suspected gynecological cancer. About 160 women will take part, and researchers will measure pain, mood, and sleep quality. The goal is to find simple, at-home way…
Phase: PHASE3 • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Can taking photos help kids with ADHD manage emotions?
Symptom relief OngoingThis study explores whether a photography-based program can help children aged 8-12 with ADHD better recognize and express emotions, and improve attention and impulsivity. Sixty children will take photos and learn photography skills as a tool to boost emotional well-being. The go…
Phase: NA • Sponsor: The Hong Kong Polytechnic University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New short therapy shows promise for anorexia recovery
Symptom relief ENROLLING_BY_INVITATIONThis study tests a new 20-session cognitive-behavioral therapy for adults aged 18 and older with anorexia nervosa. The goal is to help participants gain weight and reduce eating disorder thoughts and behaviors. Researchers will track changes in weight, anxiety, depression, and ea…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New therapy targets brain's reward system to help smokers quit
Symptom relief OngoingThis study tests whether a type of counseling called behavioral activation therapy, combined with a nicotine patch, helps people quit smoking. It focuses on smokers who have low reward sensitivity, meaning they get less pleasure from rewards. About 85 participants will receive ei…
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 13:08 UTC
-
Cancer survivors find hope in Peer-Led Self-Management program
Symptom relief OngoingThis study tests a 7-session, peer-led self-management program for 234 cancer survivors who recently finished treatment with curative intent. The program aims to reduce anxiety and depression by teaching symptom management skills in a group setting. Participants are from central …
Phase: NA • Sponsor: University of Aarhus • Aim: Symptom relief
Last updated Jun 27, 2026 13:08 UTC
-
Can a PTSD app boost alcohol recovery?
Symptom relief OngoingThis study tests whether a mobile app for PTSD, along with brief weekly support sessions, can help people who are already in treatment for alcohol problems. About 300 adults with both PTSD and alcohol use disorder will use the app or receive standard care. Researchers will track …
Phase: NA • Sponsor: Michigan State University • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Behavioral therapy may beat medication for Hair-Pulling and Skin-Picking
Symptom relief OngoingThis study compares two treatments for body-focused repetitive behaviors like hair-pulling (trichotillomania) and skin-picking disorder. 26 adults will first take memantine (a drug) for 8 weeks, then receive 8 weeks of behavioral therapy. Researchers want to see which approach re…
Phase: PHASE2, PHASE3 • Sponsor: University of Chicago • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Can a common antidepressant help cancer patients eat better?
Symptom relief OngoingThis study looks at whether mirtazapine, a drug often used for depression, can improve appetite in people with advanced cancer who have lost weight and have little desire to eat. About 98 patients will receive either mirtazapine or a placebo for 29 days. Researchers will track ch…
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Could light therapy lift mood in young transplant patients?
Symptom relief TerminatedThis study planned to see if wearing light therapy glasses could help reduce depression and tiredness in children and teens who had a stem cell transplant. Participants would have used the glasses for about four weeks while their mood and sleep were tracked. However, the study wa…
Phase: NA • Sponsor: St. Jude Children's Research Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Can a handbook ease the stress of loving someone with addiction?
Symptom relief OngoingThis study tests whether a self-help handbook called the 5-Step Method can help family members cope with the stress of a relative's drug or alcohol misuse. 24 adults in the US will be split into two groups: one gets the handbook, the other does not. The goal is to see if the prog…
Phase: NA • Sponsor: Villanova University • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Could a Parkinson's drug tame OCD?
Symptom relief OngoingThis study tests whether tolcapone, a drug used for Parkinson's disease, can reduce symptoms of obsessive-compulsive disorder (OCD) in adults. About 49 people with moderate to severe OCD will receive either tolcapone or a placebo. The main goal is to see if the drug safely lowers…
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
New group therapy aims to heal earthquake grief
Symptom relief OngoingThis study tests a structured 8-session group therapy called Integrated Grief Therapy (IGT) for adults who lost loved ones in the 2023 Türkiye earthquake. 190 survivors were randomly assigned to either the therapy or a waitlist. The goal is to see if the therapy boosts resilience…
Phase: NA • Sponsor: Sakarya University • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Herbal calm: chamomile and valerian tested for Kids' dental fears
Symptom relief OngoingThis study tests whether chamomile or valerian extracts can reduce dental anxiety in healthy children aged 6 to 10 who need a tooth pulled. Kids are randomly given one of the herbal extracts or a placebo before the procedure. Researchers measure anxiety using child-friendly emoji…
Phase: NA • Sponsor: Damascus University • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Two-Day therapy shows promise for depression relief
Symptom relief OngoingThis study tests whether a new type of group therapy, called Group Cognitive Evolutionary Therapy, can help reduce symptoms of depression and anxiety. Sixty-four adults with mild to severe depression will either receive two full days of therapy or be placed on a waiting list. Res…
Phase: NA • Sponsor: University of Bucharest • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
New CalmER therapy aims to lower anxiety in hospital staff
Symptom relief OngoingThis study tests whether a new therapy called Emotional Resolution (EmRes) can help reduce anxiety in healthcare workers. About 150 hospital workers with mild to moderate anxiety will either receive EmRes or a mindfulness-based gratitude exercise. The goal is to see if EmRes lead…
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Ketamine KETTLE trial: a single infusion to ease anorexia distress
Symptom relief ENROLLING_BY_INVITATIONThis Phase 2 trial tests a single intravenous dose of ketamine in 20 hospitalized teens and young adults with anorexia nervosa or atypical anorexia. Researchers want to see if ketamine helps the brain become more flexible, making it easier to learn new, positive associations with…
Phase: PHASE2 • Sponsor: Amanda Downey, MD • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Can VR games sharpen the minds of people with mental illness?
Symptom relief OngoingThis study tests whether virtual reality (VR) brain exercises can help people with schizophrenia or bipolar disorder think more clearly and function better in daily life. 80 adults will either receive VR training twice a week for 12 weeks or continue their usual care. Researchers…
Phase: NA • Sponsor: Università degli Studi di Brescia • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Can better sleep tame ADHD symptoms in preschoolers?
Symptom relief OngoingThis study compares two parent training programs for 3-5 year olds with sleep problems and early signs of ADHD. One program focuses on behavior, the other adds sleep strategies. Researchers want to see if the sleep-focused approach is more helpful and practical for families in pe…
Phase: NA • Sponsor: University of Pittsburgh • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Veterans' PTSD study seeks best treatment match
Symptom relief OngoingThis study compares three proven PTSD treatments—talk therapy (prolonged exposure), antidepressant medication (paroxetine or venlafaxine), and their combination—in 304 veterans. Researchers aim to identify which treatment works best for whom, using personalized algorithms. Partic…
Phase: PHASE4 • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
One-Time digital tool may help kids stuck on therapy waitlists
Symptom relief OngoingThis study tests a single online session that teaches a simple coping skill to youth ages 9-17 who are on a waitlist for therapy. The goal is to see if this quick digital tool can help ease symptoms of anxiety, depression, and stress while they wait. About 226 youth and their par…
Phase: NA • Sponsor: Harvard University • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Music and brain zaps show promise for rare movement disorder
Symptom relief OngoingThis study tests whether combining music-based movement cues (patterned sensory enhancement) with mild brain stimulation can improve arm and hand function in people with corticobasal syndrome, a rare brain disorder. Twenty participants will be split into two groups: one receiving…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Tailored talk therapy shows promise for Non-Verbal kids with autism
Symptom relief OngoingThis study tests whether personalized sequences of behavioral interventions can help minimally verbal preschoolers with autism improve their language skills. Researchers will compare two teaching approaches—JASPER (play-based) and DTT (structured)—to see which works best for each…
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
New speech therapy approach tested for kids with apraxia
Symptom relief OngoingThis study tests a speech therapy method called Rapid Syllable Transition (ReST) in children aged 5 to 8 with childhood apraxia of speech, a condition that makes it hard to say sounds correctly. The goal is to see if the therapy is practical and helps improve speech clarity and m…
Phase: NA • Sponsor: Aline Mara de Oliveira • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Can a phone app ease stress for those battling opioid addiction and past trauma?
Symptom relief ENROLLING_BY_INVITATIONThis study looks at whether a mobile mindfulness app (Headspace) can help people being treated for opioid use disorder who also have a history of childhood trauma. Sixty participants will be asked to use the app daily for 30 days and visit the clinic four times to check stress le…
Phase: NA • Sponsor: Amy Meadows • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Can rewriting your life story improve mental health? small trial tests new therapy
Symptom relief OngoingThis study tests a therapy called RETELL that helps people with severe mental illness explore and reshape their life stories. The goal is to improve personal recovery, quality of life, and identity. Twenty adults with conditions like schizophrenia, bipolar disorder, or PTSD will …
Phase: NA • Sponsor: University of Aarhus • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Music mindfulness trial aims to soothe anxious kids
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether a community-based music mindfulness program can reduce anxiety and depression in children aged 8-12 with ADHD or anxiety. Participants attend bi-weekly sessions for 8 weeks, wear fitness trackers, and complete surveys. The goal is to see if this approach …
Phase: NA • Sponsor: State University of New York at Buffalo • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
New pill aims to lift depression in days, not weeks
Symptom relief OngoingThis study tests an experimental drug called JNJ-89495120 in 107 adults with major depression. The goal is to see if it can reduce depression symptoms faster than a placebo, with checks as early as day 2 and day 5. Participants take the drug alone (no other antidepressants) and a…
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
Yoga nidra may ease stress for nursing students in clinical training
Symptom relief ENROLLING_BY_INVITATIONThis study looks at whether a guided relaxation practice called Yoga Nidra can lower stress, anxiety, and sleep problems in nursing students during their hospital training. About 110 fifth-year nursing students will take part. Researchers will measure changes using questionnaires…
Phase: NA • Sponsor: LEE CHIN-TING • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
Could nicotine patches lift depression in seniors?
Symptom relief OngoingThis study looks at whether nicotine patches can safely improve mood and thinking in adults aged 60 and older with depression. Participants who completed a previous blinded trial will wear a patch daily for up to 12 weeks, then taper off. The goal is to see if nicotine helps the …
Phase: PHASE2 • Sponsor: Vanderbilt University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
New preschool behavior program aims to ease ADHD challenges at home and school
Symptom relief ENROLLING_BY_INVITATIONThis study tests a new program called PEAR that helps parents and teachers work together to manage ADHD and disruptive behavior in preschool children aged 2-5. The program adds extra support to a proven behavior tool called the Daily Report Card. Researchers want to see if PEAR i…
Phase: NA • Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
New shot could ease pain after knee surgery for days
Symptom relief TerminatedThis study tests a single injection of F14, a long-acting form of the painkiller celecoxib, in 100 people undergoing total knee replacement. The goal is to see if it safely controls pain as part of a standard pain management plan. Participants receive the injection during surgery…
Phase: PHASE2, PHASE3 • Sponsor: Arthritis Innovation Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
New video program aims to ease suicidal thoughts in hospitalized teens
Symptom relief OngoingThis study tests a program called I-CARE for teens aged 12-17 who are in a medical hospital waiting for mental health treatment after a suicide-related emergency. The program uses 7 short videos and workbook activities to help lower emotional distress and suicidal thoughts. Resea…
Phase: NA • Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
Can a chatbot ease the pain of online bullying for depressed teens?
Symptom relief ENROLLING_BY_INVITATIONThis pilot study tests a chatbot named SMILEY that teaches coping skills and safe social media practices to marginalized youth (ages 12-18) who experience depression and online victimization. Over 4 weeks, participants interact with the chatbot at their own pace to learn how to m…
Phase: NA • Sponsor: University of Pittsburgh • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
Could nicotine patches lift depression in seniors?
Symptom relief OngoingThis study tests whether nicotine patches can improve cognitive control (like focus and memory) and mood in adults aged 60 and older with depression. Sixty participants will wear either a nicotine or placebo patch daily for 12-15 weeks. Researchers will measure changes in depress…
Phase: PHASE2 • Sponsor: Vanderbilt University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
Magic mushroom compound tested for OCD in small trial
Symptom relief OngoingThis early-stage study is testing whether repeated doses of psilocybin, the active ingredient in magic mushrooms, can reduce symptoms of obsessive-compulsive disorder (OCD). Twenty-eight adults with moderate-to-severe OCD who have not responded to standard treatments will receive…
Phase: PHASE1 • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
Sauerkraut and kimchi: a surprising remedy for long COVID?
Symptom relief ENROLLING_BY_INVITATIONThis Mayo Clinic study is testing whether eating fermented foods like yogurt, kimchi, and sauerkraut can improve gut microbiome diversity in people with long COVID. Forty adults with long COVID symptoms will either add fermented foods to their diet or continue as usual. Researche…
Phase: NA • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
New speech therapy trial aims to help korean Parkinson's patients speak clearly
Symptom relief OngoingThis study tests a remote speech therapy program for 32 Korean-speaking people with Parkinson's disease and their families. The therapy includes 16 sessions over four weeks, plus daily home practice, to improve speech clarity. The goal is to see if this culturally adapted approac…
Phase: NA • Sponsor: Florida State University • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
New app aims to make toothbrushing easier for kids with autism
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether an autism-friendly mobile app can help children and teens (ages 8-17) with autism improve their toothbrushing skills and habits. Participants use either the special app or a basic control app for 3 months while researchers track brushing quality and habit…
Phase: NA • Sponsor: University of Washington • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
Gut-Healing diet may boost recovery after critical illness
Symptom relief OngoingThis study tests whether a diet rich in fermented foods (like yogurt and kimchi) is tolerable and can improve quality of life for survivors of critical illness, including severe COVID-19. The goal is to help restore gut health and reduce inflammation. The study involves 40 partic…
Phase: NA • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Watching videos may help stop binge eating
Symptom relief OngoingThis study tests whether watching short video lessons instead of reading chapters can help adults with binge eating disorder stop binge eating. Eighty adults will either watch weekly videos or read text-based materials for 13 weeks, with brief online coaching sessions. The goal i…
Phase: NA • Sponsor: University of Sao Paulo General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Can a video chat therapy reduce suicide risk? new study hopes to find out
Symptom relief OngoingThis pilot study tests whether a brief cognitive behavioral therapy delivered via video conference can help adults with mood disorders who are at high risk for suicide. Forty participants will either receive the video therapy plus usual care, or usual care alone. The study will m…
Phase: NA • Sponsor: Hyung Keun Park • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New program aims to help veterans with COPD breathe easier and feel better
Symptom relief OngoingThis study tests an 8-week program called Step-CBT that combines physical activity goals with cognitive behavioral therapy for veterans with COPD who also have depression or anxiety. The program is delivered via video calls to make it accessible. Researchers want to see if it is …
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Could a daily probiotic help adults with autism reach personal goals?
Symptom relief OngoingThis study tests whether a probiotic supplement called Neuralli® MP can help adults aged 18 to 50 who have autistic traits. Participants take two capsules daily and set their own personal goals to track progress. The trial is small and open-label, meaning everyone knows they are …
Phase: NA • Sponsor: Mackay Memorial Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Brief therapy shows promise for suicidal inpatients
Symptom relief OngoingThis study tests a short, enhanced cognitive behavioral therapy (E-BCBT) for people hospitalized after a suicide crisis. 30 participants will either receive 5 therapy sessions during their stay or standard care. The goal is to see if this therapy reduces suicide attempts and suic…
Phase: NA • Sponsor: Hyung Keun Park • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Earpiece could cut morphine use for Opioid-Dependent newborns
Symptom relief OngoingThis study tests whether a gentle nerve-stimulating earpiece can help newborns going through opioid withdrawal. The device is used up to four times a day for 20 days, just before each morphine dose. Researchers want to see if it reduces the number of days babies need morphine and…
Phase: NA • Sponsor: Spark Biomedical, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Could a seizure drug ease pancreatitis pain and reduce opioid side effects?
Symptom relief OngoingThis early-phase trial tests whether adding lacosamide, a drug normally used for seizures, can safely help people with chronic pancreatitis who still have abdominal pain despite taking opioids. The study involves 21 adults who will take lacosamide for 7 days alongside their usual…
Phase: PHASE1 • Sponsor: Indiana University • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Could magnetic pulses to the brain ease IBS pain?
Symptom relief ENROLLING_BY_INVITATIONThis study explores whether individualized transcranial magnetic stimulation (TMS) can improve symptoms in adults with irritable bowel syndrome (IBS). Participants receive 10 TMS sessions over two weeks, with brain scans and stool tests before and after to understand how the trea…
Phase: NA • Sponsor: The Affiliated Hospital of Hangzhou Normal University • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Magic mushroom compound psilocybin tested in major depression trial
Symptom relief OngoingThis Phase 3 study tests whether a single 25 mg dose of synthetic psilocybin can reduce depression symptoms in 238 adults with major depressive disorder. Participants receive either psilocybin or a placebo, and their depression severity is measured over 43 days. The trial also lo…
Phase: PHASE3 • Sponsor: Usona Institute • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Could a facial zapping device treat depression at home?
Symptom relief OngoingThis study tests whether a device that sends mild electrical pulses to facial muscles can help treat major depression. Twenty adults with depression will use the device at home for 45 minutes daily over four weeks. The main goal is to see if the approach is feasible and safe, wit…
Phase: NA • Sponsor: Unity Health Toronto • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Which Pre-Surgery drug calms nerves and eases pain best?
Symptom relief OngoingThis study tests two medications, dexmedetomidine and tramadol, given before hemorrhoid surgery to see which one better reduces anxiety and pain. Ninety adults will receive one of the drugs or a placebo before spinal anesthesia. Researchers will measure anxiety levels and pain sc…
Phase: NA • Sponsor: Yuzuncu Yil University • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New program aims to boost Veterans' social and physical health
Symptom relief OngoingThis study tests a program called Omnis Salutis for recent veterans with PTSD, depression, anxiety, or substance use disorders. The program teaches veterans to identify their health goals and communicate them to doctors and family. Researchers want to see if it improves social an…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Non-alcoholic beer tested as a recovery aid for alcohol use disorder
Symptom relief ENROLLING_BY_INVITATIONThis pilot study is testing whether giving people non-alcoholic beer or sparkling water can help them reduce their alcohol intake. 60 adults with alcohol use disorder who are already in treatment will receive one of the two drinks for 6 weeks. The main goal is to see if people fi…
Phase: NA • Sponsor: Stanford University • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Honey and nuts may beat sugar for blood sugar control
Symptom relief OngoingThis study compares how honey versus table sugar, each paired with almonds, affects blood sugar levels, hunger, and fullness in 58 healthy premenopausal women. Participants will eat snacks containing honey or sugar with or without almonds, and their glucose will be tracked with a…
Phase: NA • Sponsor: USDA, Western Human Nutrition Research Center • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Could two weeks of therapy beat six months for anxiety?
Symptom relief OngoingThis study tests whether a short, intensive course of cognitive behavioral therapy (CBT) over 2 weeks works better than the usual weekly sessions over 6 months for people with anxiety disorders. 120 adults with conditions like panic disorder, OCD, or PTSD will be randomly assigne…
Phase: NA • Sponsor: Amsterdam UMC, location VUmc • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New app aims to ease depression after psychiatric hospitalization
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether a smartphone app can help adults who are hospitalized for depression or suicidal thoughts. After leaving the hospital, participants use the app for 28 days to practice skills that encourage positive activities. The goal is to see if the app is easy to use…
Phase: NA • Sponsor: Rutgers, The State University of New Jersey • Aim: Symptom relief
Last updated Jun 27, 2026 12:39 UTC
-
Ear-Zapping device may boost reading skills in dyslexic teens
Symptom relief TerminatedThis pilot study tests whether a non-invasive device that gently stimulates the vagus nerve through the ear can improve letter learning in 100 adolescents with dyslexia. Participants will learn new letter-sound relationships during six 30-minute sessions while receiving either ac…
Phase: NA • Sponsor: University of Florida • Aim: Symptom relief
Last updated Jun 27, 2026 12:39 UTC
-
New program aims to ease burden on families of emotionally struggling loved ones
Symptom relief OngoingThis study tests a 12-session group program called Family Connections Transdiagnostic for relatives of people with emotional dysregulation disorders (like eating disorders or personality disorders). The program teaches skills in mindfulness, emotional regulation, and problem mana…
Phase: NA • Sponsor: University of Valencia • Aim: Symptom relief
Last updated Jun 27, 2026 12:39 UTC
-
New study aims to ease caregiver stress through smart matching
Symptom relief OngoingThis study tests a new way to match dementia caregivers with each other for emotional support using a computer algorithm. Researchers want to see if matching based on personal preferences leads to better satisfaction and less stress than random matching. About 355 caregivers of p…
Phase: NA • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
Can a ketamine shot stop suicidal thoughts in minutes?
Symptom relief TerminatedThis study tests whether a single injection of ketamine can quickly reduce suicidal thoughts in people with depression who come to the emergency room. About 90 participants will receive either ketamine or a sedative (midazolam) and be monitored for 24 hours. The trial is currentl…
Phase: PHASE4 • Sponsor: New York State Psychiatric Institute • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
New app aims to ease parental stress and boost child wellbeing
Symptom relief OngoingThis study tests a free app called LightBEAM that offers videos, forums, and exercises to help parents manage stress, anxiety, and depression. About 300 Canadian parents of children aged 18 months to 9 years will use the app for 12 weeks. The goal is to see if the app improves pa…
Phase: NA • Sponsor: University of Manitoba • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
New drug shows promise for bipolar depression in early trial
Symptom relief OngoingThis study tests whether adding a new drug called ABX-002 to current treatments can improve depression symptoms in adults with bipolar disorder. About 30 people with bipolar depression will take the drug for 6 weeks, and some will have brain scans to see how it affects brain chem…
Phase: PHASE2 • Sponsor: Autobahn Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
VR headsets aim to ease OCD brain treatment — but study pulled
Symptom relief TerminatedThis study planned to see if using virtual reality (VR) before a brain stimulation treatment called TMS could help people with OCD feel more comfortable. It was designed for adults already approved for TMS. However, the study was withdrawn before any participants were enrolled, s…
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
Can flickering lights and tones slow Alzheimer's? MIT trial begins
Symptom relief OngoingThis study tests whether using a device that delivers light and sound stimulation for 60 minutes each day is safe and practical for people with mild Alzheimer's. Fifteen participants will use the device at home for 6 to 9 months. The main goals are to see if people can stick with…
Phase: NA • Sponsor: Massachusetts Institute of Technology • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
Can Home-Based palliative care ease dementia suffering?
Symptom relief OngoingThis study tests whether a team of doctors, nurses, social workers, and community health workers providing palliative care at home can improve symptom control and reduce hospital visits for people with advanced dementia. About 153 patients and their family caregivers are taking p…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
New drug aims to curb impulsive behavior in opioid addiction
Symptom relief TerminatedThis early-stage trial tests whether a daily tablet called BI 1356225 can improve impulse control in people with opioid use disorder who are already taking buprenorphine. About 60 participants will be randomly assigned to receive either the study drug or a placebo for 8 days. Res…
Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
PTSD therapy gets a voice twist: study tests emotional tone shifting
Symptom relief TerminatedThis study aimed to see if a voice-changing device could make exposure therapy easier for people with PTSD. Patients would read their trauma story aloud while software altered their voice's emotional tone, hoping to reduce distress. The study was withdrawn before any participants…
Phase: NA • Sponsor: University Hospital, Lille • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Nasal spray aims to calm social anxiety fast in public speaking situations
Symptom relief OngoingThis study tests an experimental nasal spray called fasedienol for quickly reducing anxiety during a public speaking challenge in adults with social anxiety disorder. About 238 participants will receive either the spray or a placebo and rate their distress levels. The goal is to …
Phase: PHASE3 • Sponsor: VistaGen Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Can PTSD therapy help people stick with opioid treatment?
Symptom relief OngoingThis study tests whether an adapted version of Cognitive Processing Therapy (CPT), delivered via telehealth at syringe service programs, can reduce PTSD symptoms and help people stay on their opioid use disorder medication. Eleven adults who regularly use syringe services and are…
Phase: NA • Sponsor: The City College of New York • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
New depression drug SPT-300 moves to safety testing in extension trial
Symptom relief ENROLLING_BY_INVITATIONThis study is an extension of an earlier trial, testing the safety and tolerability of SPT-300 in 360 adults with major depressive disorder, with or without anxious distress. Participants who completed the prior study will receive SPT-300 for 6 weeks. The goal is to monitor side …
Phase: PHASE2 • Sponsor: Seaport Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Common antidepressant fluoxetine put to the test for PTSD relief
Symptom relief TerminatedThis Phase 2 study is testing whether fluoxetine, a common antidepressant, can safely reduce PTSD symptoms in active-duty service members, veterans, and civilians. About 200 participants will receive either fluoxetine or a placebo for up to 12 weeks. The main goal is to see if PT…
Phase: PHASE2 • Sponsor: Global Coalition for Adaptive Research • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
New hope for PTSD: experimental drug trial targets service members and veterans
Symptom relief TerminatedThis study tests an experimental drug called SLS-002 to see if it can safely reduce PTSD symptoms in active-duty service members, veterans, and civilians. About 200 participants will receive either the drug or a placebo twice a week for 8 weeks, then once a week for 4 more weeks.…
Phase: PHASE2 • Sponsor: Global Coalition for Adaptive Research • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Can a phone app and a coach help Spanish-Speaking patients beat depression?
Symptom relief ENROLLING_BY_INVITATIONThis study tests a digital cognitive behavioral therapy program (SilverCloud) for Spanish-speaking adults with depression or anxiety. 426 participants will either use the program on their own or get extra support from a peer coach via phone or messaging. The goal is to see if add…
Phase: NA • Sponsor: University of California, Irvine • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Zapping the brain with personalized alpha waves to fight schizophrenia symptoms
Symptom relief OngoingThis study tests whether a more targeted form of transcranial magnetic stimulation (TMS) can help people with schizophrenia whose symptoms don't improve with medication. The treatment uses each patient's own brain wave frequency (alpha rhythm) and MRI scans to precisely stimulate…
Phase: NA • Sponsor: Niuvanniemi Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Can live music soothe severe dementia? new trial hopes to find out
Symptom relief OngoingThis pilot study tests a live music therapy program called AMUSED for older adults with severe dementia living in care facilities. Participants attend small group sessions twice a week for 12 weeks, either with music therapy or a reading activity. Researchers want to see if music…
Phase: NA • Sponsor: Alaine E Hernandez, PhD • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Can brain zaps boost social skills in kids with autism?
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether 80 sessions of a gentle brain stimulation technique called tDCS, given over 12 months, can improve attention, social skills, and language in 180 children aged 6 to 11 who have autism along with rare diseases, genetic problems, or PANDAS. The treatment is …
Phase: PHASE1 • Sponsor: Spanish Foundation for Neurometrics Development • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Magic mushroom compound tested for stubborn OCD
Symptom relief ENROLLING_BY_INVITATIONThis small early-phase study is testing whether psilocybin, the active ingredient in magic mushrooms, combined with supportive therapy can safely help people with obsessive-compulsive disorder (OCD) that hasn't responded to standard treatments. Ten adults with treatment-resistant…
Phase: PHASE1 • Sponsor: Centre for Addiction and Mental Health • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Mindfulness may ease stress and anxiety in COPD patients, small study suggests
Symptom relief OngoingThis pilot study tests whether an 8-week mindfulness program (MBSR) can reduce anxiety, depression, and stress in people with COPD who are already in pulmonary rehab. About 44 participants will be followed for 12 months. The goal is to see if this mind-body approach improves emot…
Phase: NA • Sponsor: Université Libre de Bruxelles • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Brain zaps and VR games: a new hope for MS symptoms?
Symptom relief OngoingThis study tests whether combining transcranial magnetic stimulation (TMS) with virtual reality exercises and physical therapy can improve symptoms like balance, fatigue, and thinking in people with multiple sclerosis. Thirty participants will receive both real and sham TMS in a …
Phase: NA • Sponsor: University of Sao Paulo • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
New pill aims to quiet Schizophrenia's worst symptoms
Symptom relief OngoingThis study tests an experimental oral medication, ML-007C-MA, in 307 adults hospitalized with schizophrenia who are having a sudden worsening of psychosis. The goal is to see if the drug reduces symptoms like hallucinations and delusions better than a placebo. Participants take t…
Phase: PHASE2 • Sponsor: MapLight Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Nose spray vs. syrup: which stops Kids' Post-Surgery delirium best?
Symptom relief ENROLLING_BY_INVITATIONThis study looks at two medicines given before surgery to prevent delirium (confusion and agitation) in children aged 3 months to 9 years. One is a nose spray (dexmedetomidine), the other is a syrup (midazolam). The goal is to see which works better and is easier for kids to take…
Phase: PHASE4 • Sponsor: University of Massachusetts, Worcester • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Morning or afternoon? study tests best time for PTSD therapy
Symptom relief OngoingThis study looks at whether having therapy sessions in the morning or afternoon changes how well prolonged exposure therapy works for PTSD. About 52 adults with PTSD will receive 10 weekly therapy sessions via telehealth, either early in the day or late afternoon. Researchers wil…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Can talking about your thoughts help treat eating disorders?
Symptom relief OngoingThis pilot study is testing a type of talk therapy called Metacognitive Interpersonal Therapy (MIT-ED) for adults with various eating disorders, including those who are underweight. The therapy aims to help people understand and manage the negative thoughts and feelings that driv…
Phase: NA • Sponsor: GLORIA FIORAVANTI • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Video game workout from home boosts brain and balance in seniors
Symptom relief OngoingThis study tests a home-based exercise program for older adults with mild cognitive impairment or dementia. Participants play a specially designed game while a therapist supervises them remotely via telemedicine. The goal is to see if this approach can improve balance and thinkin…
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Yoga before birth may ease postpartum blues, study finds
Symptom relief OngoingThis study looks at whether an 8-week yoga program during pregnancy can lower the risk of postpartum depression and strengthen the bond between mother and baby. It involves 60 first-time mothers who are 26-28 weeks pregnant. Participants will either take yoga classes or receive s…
Phase: NA • Sponsor: Muş Alparslan University • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Can a blood test predict who will respond to ketamine for depression?
Knowledge-focused OngoingThis study investigates whether changes in brain chemicals (GABA and glutamate) can predict who will respond to ketamine for treatment-resistant depression. Researchers will give two intravenous ketamine infusions to 18 adults and measure chemical levels in the brain and blood. T…
Phase: EARLY_PHASE1 • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
New tool aims to improve how we track street opioid use
Knowledge-focused ENROLLING_BY_INVITATIONThis study tests a new interview tool called the Opioid Timeline Follow-Back (OpiTLFB) to better track nonmedical opioid use, including fentanyl. Thirty adults who use opioids at least once a week will fill out a calendar and answer questions about their drug use over the past 30…
Sponsor: National Institute on Drug Abuse (NIDA) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Brain scans reveal secrets of lost smell
Knowledge-focused ENROLLING_BY_INVITATIONThis study tracks 80 adults with different smell disorders (like total loss, partial loss, or distorted smell) plus healthy volunteers over one year. Researchers use brain scans, smell tests, and questionnaires to see how the brain changes and how smell loss impacts mood and dail…
Sponsor: National Institute on Deafness and Other Communication Disorders (NIDCD) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Zapping the brain to make better choices: a new hope for opioid addiction?
Knowledge-focused TerminatedThis study looks at whether transcranial magnetic stimulation (TMS) can change how people with opioid use disorder and healthy volunteers make risky or uncertain decisions. Participants will have MRI scans and computer tasks, and some will receive real or sham TMS. The goal is to…
Phase: NA • Sponsor: National Institute on Drug Abuse (NIDA) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
New study tracks rare disease SCA7 to uncover clues for future treatments
Knowledge-focused OngoingThis study follows 25 people with spinocerebellar ataxia type 7 (SCA7) for up to 5 years to learn how the disease changes vision, coordination, and thinking. Participants will have yearly eye exams, brain scans, and neurological tests. No treatment is given; the goal is to gather…
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Love hormone nasal spray tested for borderline personality disorder trust issues
Knowledge-focused TerminatedThis pilot study looks at whether a nasal spray of oxytocin, sometimes called the 'love hormone,' can improve trust and cooperation in people with borderline personality disorder (BPD). About 40 participants (some with BPD, some healthy) will play a trust game after receiving eit…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
New program aims to help seniors recover from Post-Surgery confusion
Knowledge-focused OngoingThis study looks at whether a special recovery program can help older adults (65+) who experienced confusion (delirium) after emergency surgery. Participants will have virtual visits with a care coordinator and complete physical, cognitive, and psychological assessments over 18 m…
Phase: NA • Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Jail-Based program aims to boost HIV testing and PrEP access for incarcerated individuals
Knowledge-focused OngoingThis study examines a program in two Boston-area jails designed to make HIV testing and treatment easier for people with opioid use disorder. Researchers will follow about 59 participants who are leaving jail within a month to see if they use HIV services, get tested, or take PrE…
Sponsor: Boston Medical Center • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Brain scan study tracks why Parkinson's patients fall and forget
Knowledge-focused OngoingThis study follows 125 people with Parkinson's disease or related conditions over two years. Researchers use special brain scans to measure changes in a chemical called acetylcholine, which is linked to walking problems, falls, and thinking skills. The goal is to understand how t…
Phase: NA • Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
New study aims to make opioid courts more effective at saving lives
Knowledge-focused OngoingThis study looks at how to improve opioid court programs in New York State. Researchers will work with court staff and treatment providers to help defendants quickly get medication for opioid use disorder. The goal is to see if these strategies increase treatment retention, reduc…
Phase: NA • Sponsor: New York State Psychiatric Institute • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Knee replacement recovery: how many still have pain after 3 months?
Knowledge-focused OngoingThis study follows adults who have knee replacement surgery using a fast-track recovery program called ERAS. Researchers want to know how many people still have pain three months later, how severe it is, and whether they still need strong painkillers. Participants answer simple q…
Sponsor: University Hospital, Ghent • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Brain scans may predict recovery from ICU delirium in lung failure patients
Knowledge-focused TerminatedThis study investigates cognitive problems in intensive care patients with acute respiratory distress syndrome (ARDS) who develop delirium (sudden confusion). Researchers use a non-invasive EEG cap and auditory tests to measure brain activity at the bedside. The goal is to identi…
Phase: NA • Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Can ketamine help new moms after C-Section? early study suspended
Knowledge-focused TerminatedThis Phase 1 study aims to understand how the body processes ketamine after a cesarean delivery, and whether it can help with postpartum depression and pain. Fifty participants will receive a low-dose ketamine infusion, and researchers will measure drug levels and side effects. T…
Phase: PHASE1 • Sponsor: University of Utah • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Scientists map the Brain's speech decoder
Knowledge-focused ENROLLING_BY_INVITATIONThis study investigates how the brain processes speech sounds to understand language. Researchers will record brain activity from people with epilepsy or brain tumors who already have electrodes implanted for medical reasons. Participants listen to short speech sounds while their…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
French researchers dive into gambling addiction: first detailed look at At-Risk players
Knowledge-focused UNKNOWN_STATUSThis study aims to describe French gamblers who are at risk or have a pathological gambling problem. Researchers will collect information on their gambling history, personality, and other health issues. The goal is to compare this data with studies from other countries and to tes…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Alzheimer's gut study pulled before it even started
Knowledge-focused TerminatedThis study aimed to see if Alzheimer's disease affects the nerves in the gut, similar to what happens in Parkinson's disease. Researchers planned to take extra colon biopsies during routine colonoscopies from people with Alzheimer's, Parkinson's, and healthy individuals to compar…
Phase: NA • Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Brain test could revolutionize alcohol addiction treatment
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to test a new assessment tool called the ANA, which uses surveys and computer tasks to measure three key brain functions related to addiction. Researchers will study 1,400 adults with alcohol use disorder to see how these brain functions relate to drinking behavio…
Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Brain training after injury: who benefits most?
Knowledge-focused OngoingThis study looks at whether intensive computer-based brain exercises can improve memory, attention, and problem-solving in people who have had a brain injury. Thirty adults aged 25-65 with mild cognitive problems will train on a computer for 45-60 minutes a day, five days a week,…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Can a One-Page guide spark better End-of-Life talks for dementia patients?
Knowledge-focused OngoingThis study tests a short guide called the 'Jumpstart Guide' to help doctors have better conversations with dementia patients and their families about healthcare goals. Over 1,800 patients and their caregivers are taking part. Researchers will compare whether those whose doctors u…
Phase: NA • Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
New study aims to improve care for young people with psychosis
Knowledge-focused TerminatedThis study is creating a learning healthcare system for OnTrackNY, a program that helps young people (ages 16-30) who have recently experienced psychosis. Researchers will collect data and feedback from participants, families, and clinicians to continuously improve care. The goal…
Sponsor: New York State Psychiatric Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Simple blood test may spot hidden liver trouble in colitis patients
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at whether two blood markers, zonulin and LBP, can help detect liver damage in people with both ulcerative colitis (UC) and fatty liver disease. Researchers will measure these markers and use a special ultrasound to check liver stiffness in 100 adults with UC who…
Sponsor: University Hospital Dubrava • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Scientists watch the Brain's emotion network in real time
Knowledge-focused ENROLLING_BY_INVITATIONThis study investigates how the brain's emotion network works by recording brain activity directly from the surface of the brain in people with epilepsy who are already undergoing surgery for seizure monitoring. Participants watch short video clips designed to trigger emotions li…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Can therapy rewire the PTSD brain? new study investigates
Knowledge-focused ENROLLING_BY_INVITATIONThis study tracks 130 adults with PTSD from childhood trauma as they undergo Cognitive Processing Therapy. Researchers will measure brain activity, genetics, and behavior before and after treatment to understand how recovery happens. The goal is to uncover biological markers of P…
Sponsor: Milissa Kaufman • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Brain fog in fibromyalgia: study probes hidden links to thinking skills
Knowledge-focused ENROLLING_BY_INVITATIONThis study investigates factors that may influence cognitive skills—like memory, attention, and problem-solving—in women diagnosed with fibromyalgia. Researchers will assess thinking abilities using a detailed cognitive test and measure how fibromyalgia affects daily life. The go…
Sponsor: Zülal TATAR • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Nurse Well-Being under the microscope: 21,300 mayo nurses surveyed for moral injury and PTSD
Knowledge-focused ENROLLING_BY_INVITATIONThis study surveys over 21,000 nurses at Mayo Clinic to measure levels of moral distress, moral injury, and post-traumatic stress. Participants fill out questionnaires about their experiences and well-being. The goal is to understand how these issues vary by work setting, special…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Scientists probe the vagus nerve: what happens when It's stimulated?
Knowledge-focused OngoingThis study looks at how vagus nerve stimulation (VNS) affects the nervous system, heart, immune system, and metabolism in people who already have a VNS device for epilepsy or depression. Researchers will measure things like nerve activity, blood pressure, and heart rate during di…
Phase: NA • Sponsor: University of Minnesota • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Massive 30-Year Women's health study reveals hidden disease links
Knowledge-focused OngoingThis long-running study follows nearly 100,000 French women, mostly teachers, since 1990 to understand what factors influence their risk of cancer, heart disease, diabetes, and other major illnesses. Participants fill out questionnaires every few years about their lifestyle, medi…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Alzheimer's risk test results: what happens when you find out?
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at how adults at risk for Alzheimer's disease react after learning their amyloid and tau biomarker test results. Researchers will track changes in distress, stigma, quality of life, and future planning over time. The goal is to understand the psychological and be…
Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Brain scans reveal hidden scars of childhood abuse in women
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at how childhood abuse and neglect change the brain in women with PTSD or dissociative identity disorder. Researchers will use MRI scans and cognitive tests to measure brain activity related to attention, emotions, and feelings of detachment. The goal is to bette…
Sponsor: Mclean Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
AI chatbots for mental health: what do patients really think?
Knowledge-focused ENROLLING_BY_INVITATIONThis observational study surveys 150 adults with severe mental illness to learn how they use AI chatbots for mental health support. Participants answer a one-time anonymous online survey about their experiences, expectations, and concerns. The goal is to understand usage patterns…
Sponsor: Medizinische Hochschule Brandenburg Theodor Fontane • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
AI tool aims to predict Post-Surgery confusion in seniors
Knowledge-focused OngoingThis study tests whether an AI tool that uses electronic medical records can help predict and reduce delirium (sudden confusion) in older adults after major surgery. About 60 people aged 65 and older will take part. The goal is to see if giving doctors a delirium risk alert can l…
Phase: NA • Sponsor: Indiana University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Sleep therapy study for ADHD teens pulled before start
Knowledge-focused TerminatedThis study was designed to see if cognitive behavioral therapy for insomnia (CBT-I) could help teenagers with ADHD who also have trouble sleeping. It planned to enroll adolescents aged 11-18 with both ADHD and insomnia. However, the trial was withdrawn before any participants wer…
Phase: NA • Sponsor: The University of Hong Kong • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Bipolar brain study pulled before starting
Knowledge-focused TerminatedThis study was designed to compare decision-making skills between bipolar patients who had attempted suicide and those who had not. Researchers planned to use computer tasks and questionnaires to measure thinking patterns. However, the study was withdrawn before enrolling any par…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Massive gene hunt aims to unlock bipolar Disorder's secrets
Knowledge-focused OngoingThis study aims to find genes that may increase the risk of developing bipolar disorder. Researchers are collecting DNA and health information from 4,185 adults to understand the genetic causes of the condition. The goal is to improve diagnosis and treatment in the future, but th…
Sponsor: National Institute of Mental Health (NIMH) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Simple blood draws could spot dementia years early
Knowledge-focused OngoingThis study tracks a protein called neurofilament light chain in the blood of 342 people who carry genetic mutations linked to frontotemporal dementia (FTD). Participants provide blood samples every three months for three years, often from home. The goal is to see if this biomarke…
Sponsor: The Bluefield Project to Cure Frontotemporal Dementia • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Scientists hunt for genetic clues to autism
Knowledge-focused OngoingThis study aims to uncover the genetic and environmental factors behind autism spectrum disorders (ASD), including autism, Asperger's syndrome, and PDD. Researchers will analyze gene expression in 240 participants aged 18 months and older who have an ASD diagnosis. The goal is to…
Sponsor: Boston Children's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
AI and gut bacteria may predict who gets hooked on opioids
Knowledge-focused OngoingThis study aims to validate two new tools that use artificial intelligence to predict a person's risk of developing opioid use disorder. One tool looks at genetic markers, and the other examines gut bacteria. Researchers will enroll 300 adults with or without opioid addiction to …
Sponsor: University of California, San Diego • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
10-Year depression study aims to unlock personalized treatment clues
Knowledge-focused OngoingThis study follows 2,500 people aged 10 and older with depression or bipolar depression over 10 years. Researchers collect data on symptoms, brain scans, genetics, and lifestyle to find patterns that predict how someone will respond to different treatments. No experimental drugs …
Sponsor: University of Texas Southwestern Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
MRI scans reveal brain secrets in kids with ADHD, autism, and more
Knowledge-focused OngoingThis study uses MRI scans to look at the brains of children and adults with conditions like ADHD, autism, schizophrenia, and endocrine disorders, as well as healthy volunteers. Researchers aim to compare brain anatomy and function across different groups and ages. The goal is to …
Sponsor: National Institute of Mental Health (NIMH) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Cancer kids show surprising strength: study reveals growth, not just trauma
Knowledge-focused OngoingThis study looks at how children with cancer and their parents handle the emotional challenges of the disease. Instead of focusing only on negative effects like posttraumatic stress, researchers also explore positive changes, such as personal growth. The study compares these fami…
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Appalachia study tests tobacco rules in simulated store
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at how proposed tobacco regulations might affect the buying and use habits of people in Appalachian Kentucky. About 473 adults who use tobacco daily will take online surveys and shop in a pretend online store where prices change. The goal is to see if rules like …
Phase: NA • Sponsor: Mikhail N Koffarnus • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Massive Alzheimer's study aims to unlock secrets of memory loss
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows 1,500 volunteers with normal memory, mild cognitive impairment, or Alzheimer's over several years. Researchers use brain scans, memory tests, and blood samples to track how the disease progresses. The goal is to find better ways to diagnose and treat Alzheimer'…
Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Short walks beat one big workout for Kids' health?
Knowledge-focused OngoingThis study looks at whether taking short walks throughout the day is better for kids at risk for type 2 diabetes than one longer exercise session. Researchers will measure blood sugar, insulin, and thinking skills in 188 children aged 8-11 with overweight or obesity. The goal is …
Phase: NA • Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Cooling agents in vapes: do they make them more addictive?
Knowledge-focused OngoingThis study looks at how synthetic cooling additives (like WS-3 and WS-23) in e-cigarettes change how young adults perceive and use them. About 158 current e-cigarette users aged 21-29 will try different flavored e-liquids and report their satisfaction, sensory experiences, and pu…
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Can the liver heal itself? new study tracks unexpected recovery in cirrhosis patients
Knowledge-focused OngoingThis study looks at 300 patients with advanced liver scarring (cirrhosis) caused by hepatitis B or alcohol who have shown signs of getting better. Researchers want to understand what predicts this improvement and how long it lasts. The goal is to create clearer guidelines for whe…
Sponsor: Third Affiliated Hospital, Sun Yat-Sen University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Scientists hunt for clues in genes and body fluids to unlock ALS mysteries
Knowledge-focused OngoingThis study is observing 217 people with ALS and related conditions like frontotemporal dementia and hereditary spastic paraplegia. Researchers aim to connect each person's genetic makeup with their symptoms and find biological markers in blood and spinal fluid. No new treatments …
Sponsor: University of Miami • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Biggest ALS gene study aims to unlock disease secrets
Knowledge-focused OngoingThis study looks at people with ALS and similar diseases like frontotemporal dementia and hereditary spastic paraplegia. Researchers want to understand how genes affect the disease and find biological markers (biomarkers) to help develop future treatments. About 708 participants,…
Sponsor: University of Miami • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
AI and wearables join forces to uncover Dementia's hidden clues
Knowledge-focused OngoingThis study investigates how genetic, lifestyle, and biological factors relate to memory and thinking problems in people over 60 with Alzheimer's disease, Parkinson's disease, or mild cognitive impairment. Researchers will use brain scans, spinal fluid and blood tests, and data fr…
Sponsor: IRCCS San Raffaele Roma • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Massive study launches to unlock secrets of spinal cord and brain injuries
Knowledge-focused ENROLLING_BY_INVITATIONThis large observational study aims to collect medical data and biological samples from up to 5,000 people with chronic spinal cord injury or traumatic brain injury, as well as their family members and healthy volunteers. Researchers hope this information will help them better un…
Sponsor: The University of Texas Health Science Center, Houston • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Groundbreaking study aims to speed up ALS treatment development
Knowledge-focused OngoingThis study enrolls people with ALS and related disorders, as well as healthy volunteers, to track biological markers (biomarkers) in urine, blood, and spinal fluid. The goal is to better understand how these markers change over time, which could help design more effective future …
Sponsor: University of Miami • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Can peers help people recover from mental illness? new study says maybe
Knowledge-focused OngoingThis study tests a 10-week program called 'Grow to Recovery' for people with mental illness. The program is co-led by a peer (someone who also has a mental illness) and a professional. Researchers want to see if it helps participants feel more hopeful and capable. 138 people are …
Phase: NA • Sponsor: National Cheng-Kung University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Anxiety may hold key to depression treatment resistance
Knowledge-focused OngoingThis study explores how anxiety contributes to treatment-resistant depression. Researchers will follow 37 adults with depression to see if anxiety levels can predict who will have a harder time recovering. The goal is to better identify at-risk patients and develop more targeted …
Phase: NA • Sponsor: Rennes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:08 UTC
-
Can a Parent-Teen driving program cut risky driving in teens?
Knowledge-focused OngoingThis study tests a program that helps parents and teens work together to improve safe driving. It includes 588 teens aged 16-17 who have already received a traffic ticket. The program uses a smartphone app and in-car device to track risky driving and give feedback, aiming to redu…
Phase: PHASE3 • Sponsor: Ginger Yang • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
New brain scan study aims to uncover dementia clues in african americans
Knowledge-focused ENROLLING_BY_INVITATIONThis study uses a special PET scan to look at tau protein buildup in the brains of African Americans who are either cognitively normal or have dementia. Researchers hope to learn how these brain changes differ across racial groups. The study involves 240 participants and uses a t…
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Brain scans and a new drug combo aim to break the cycle of depressive rumination
Knowledge-focused OngoingThis study looks at whether adding aripiprazole to the antidepressant escitalopram can reduce pathological rumination—repetitive, intrusive negative thoughts—in people with major depressive disorder. 108 participants will receive either escitalopram alone or escitalopram plus ari…
Phase: NA • Sponsor: Central South University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Can remote trials work as well as in-person? new study aims to find out.
Knowledge-focused OngoingThis study tests whether doing clinical trial visits remotely (from home) works as well as coming into a clinic. About 200 adults will be randomly assigned to remote or in-person groups for intake and follow-up over 3 months. The goal is to see which method is better at keeping p…
Phase: PHASE2, PHASE3 • Sponsor: State University of New York at Buffalo • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Study explores lasting effects of childbirth injury on pelvic and sexual health
Knowledge-focused ENROLLING_BY_INVITATIONThis observational study follows 600 women who had an anal sphincter injury during childbirth in Finland between 2009 and 2021. Researchers want to understand how common long-term pelvic floor symptoms and sexual problems are after such injuries. Participants fill out questionnai…
Sponsor: Tampere University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
New study aims to close heart health gap for those with mental illness
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at how to best help people with serious mental illness take part in a program that lowers heart disease risk. Researchers will test different support strategies at community mental health clinics in Michigan and Maryland. The goal is to find the most effective wa…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Ketamine's brain impact under the scanner: new study targets synaptic loss
Knowledge-focused OngoingThis study uses PET and MRI scans to measure brain cell connections in people with major depression or PTSD. Researchers will give ketamine to see if it can reverse synaptic loss linked to these conditions. The goal is to understand brain changes, not to provide treatment. About …
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Mindfulness may rewire brains of teens at risk for depression
Knowledge-focused OngoingThis study looks at whether a mindfulness program can improve attention and brain connectivity in 11-14 year olds who have a family history of mood disorders and high mood swings. About 224 teens will be randomly assigned to mindfulness or a health education class. The goal is to…
Phase: NA • Sponsor: University of Pittsburgh • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Brain scans reveal overlap in social thinking in autism and schizophrenia
Knowledge-focused OngoingThis study uses brain scans and behavioral data from 267 adults (80 with autism, 79 with schizophrenia, and 108 healthy controls) to explore shared brain activity patterns related to social thinking. No new treatments are given; researchers analyze existing data to understand how…
Sponsor: National Taiwan University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Can fear of pain change how you walk? new study investigates
Knowledge-focused OngoingThis study looks at how fear of pain affects movement in 26 healthy adults. Researchers used verbal suggestions and inactive electrodes to create a sense of threat during walking and arm-pointing tasks. The goal is to understand how fear of movement changes walking speed, stride,…
Phase: NA • Sponsor: Universite de Picardie Jules Verne • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
New study uses community events to spark End-of-Life conversations
Knowledge-focused OngoingThis study aims to help people from underserved communities talk about their wishes for end-of-life care and complete advance directives. Researchers will use trusted community networks to host events where two conversation tools are tested. About 1500 adults will participate to …
Phase: NA • Sponsor: Milton S. Hershey Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Radioactive tracer reveals tau tangles in Alzheimer's brains
Knowledge-focused ENROLLING_BY_INVITATIONThis study tests a new radioactive compound called F 18 T807 that lights up tau tangles in the brain during a PET scan. Researchers want to see if the amount of tau relates to memory and thinking problems in people with a rare, inherited form of Alzheimer's disease. About 130 adu…
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
New brain scan tracks Alzheimer's protein in real time
Knowledge-focused ENROLLING_BY_INVITATIONThis study uses a radioactive tracer called [18F]MK-6240 to take detailed pictures of tau protein clumps in the brain, a hallmark of Alzheimer's disease. Researchers will scan 200 people from families with a rare genetic form of Alzheimer's to see how tau buildup changes over tim…
Sponsor: Tammie L. S. Benzinger, MD, PhD • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Should kids stop bladder meds slowly or all at once? study aims to find out
Knowledge-focused OngoingThis study looks at the best way to stop bladder control medication in children aged 5 to 14 who are currently dry. Some children will stop their medicine suddenly, while others will taper off gradually. The goal is to see which approach lowers the chance of wetting accidents ret…
Phase: PHASE4 • Sponsor: University of Aarhus • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Brain waves during sleep may reveal Depression-Insomnia link
Knowledge-focused OngoingThis study looks at sleep patterns in 94 adults with major depressive disorder, comparing those with moderate-to-severe insomnia to those with mild or no insomnia. Participants wear a headband at home that records brain activity during sleep and also fill out sleep diaries and qu…
Sponsor: Janssen Research & Development, LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Depression's hidden toll on male sexual function revealed
Knowledge-focused OngoingThis study looks at how the severity of depression relates to erectile dysfunction and premature ejaculation in 100 married men aged 25–60 in the Sohag region of Egypt. Participants are clinically diagnosed with depression and sexually active. Researchers will use standard questi…
Sponsor: Sohag University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Study reveals hidden lung damage from secondhand smoke in flight attendants
Knowledge-focused OngoingThis study looks at how long-term exposure to secondhand tobacco smoke changes the lungs of never-smoking flight attendants who worked on planes before smoking was banned. Researchers want to see if a bronchodilator, a medicine that opens airways, can help with breathing problems…
Phase: PHASE4 • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Liver's Fat-Burning secrets revealed in sleeve gastrectomy study
Knowledge-focused OngoingThis study looks at how the liver burns fat and makes sugar in people with NASH (a serious liver disease linked to obesity) who are planning to have weight-loss surgery. Researchers will use special scans to measure liver function before and after surgery in 30 adults. The goal i…
Phase: NA • Sponsor: University of Minnesota • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Which country handles mentally ill offenders better? a Head-to-Head study
Knowledge-focused OngoingThis study follows 600 mentally ill offenders in Italy and California over three years to compare two very different treatment systems. Italy uses community-based care, while California relies on long-term hospital stays. Researchers will track violence, recovery, and functioning…
Sponsor: University of Bari • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Brain power and binge eating: new study tracks Kids' weight over time
Knowledge-focused OngoingThis study follows 180 children with overweight or obesity to see how their thinking skills (like memory and self-control) relate to eating habits and weight changes over time. Researchers will use brain tasks and interviews to understand these links. The goal is to find better w…
Sponsor: University of Pittsburgh • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
New tool aims to fairly assess Autism-Related risks in court
Knowledge-focused OngoingThis study is not a treatment trial. It aims to translate and test a new assessment tool (FARAS-IT) for adults with autism who are involved in the Italian criminal justice system. Researchers will enroll 100 adults with autism, including those in forensic psychiatric care, those …
Sponsor: University of Bari • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Can an online therapy program help with alcohol and suicidal thoughts?
Knowledge-focused OngoingThis study follows 100 adults who drink alcohol at least weekly and have some interest in cutting back. Researchers want to see how alcohol use, suicidal thoughts, and decision-making are linked. Participants get access to a self-guided online cognitive behavioral therapy program…
Phase: NA • Sponsor: Mark J Rzeszutek, PhD • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Veteran peers lead fight against opioid overdose
Knowledge-focused OngoingThis study tests a program where veteran peer workers provide education, healthcare navigation, and social support to 150 veterans with opioid use disorder who are not connected to VA healthcare. The goal is to reduce risky behaviors related to overdose and HIV/HCV infection. Res…
Phase: NA • Sponsor: New York University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
New program aims to ease HIV stigma for expectant mothers in ghana
Knowledge-focused ENROLLING_BY_INVITATIONThis study adapts an existing stigma-reduction program specifically for pregnant and postpartum women living with HIV in Ghana. Researchers will interview 30 women and 20 providers to understand their experiences, then work with stakeholders to tailor the program. Finally, 90 pre…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Sleep secrets: could better bedtimes curb childhood obesity?
Knowledge-focused OngoingThis study looks at how changing sleep patterns affects eating behavior and self-control in 120 children who are overweight or at risk for obesity. Researchers will monitor sleep, brain activity, and real-world eating to understand the link between sleep and weight gain. The goal…
Phase: NA • Sponsor: University of Pittsburgh • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Can a 'Health at every Size' approach improve pregnancy mental health?
Knowledge-focused OngoingThis study adapts a 'Health at Every Size' program for pregnant people with a BMI over 30. Ten first-time mothers will attend group sessions on nutrition, movement, and self-advocacy. The goal is to see if the program is acceptable and helpful in reducing weight stigma and improv…
Phase: NA • Sponsor: University of Massachusetts, Worcester • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Massive 10-Year study aims to unlock the secrets of teen resilience
Knowledge-focused OngoingThis 10-year study follows 1,500 young people aged 10-24 to learn what makes some more resilient to depression and anxiety than others. Researchers will track lifestyle, brain scans, and mental health over time. No treatments or interventions are given—the goal is simply to obser…
Sponsor: University of Texas Southwestern Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Can we finally spot CTE before death? new study hopes to find out
Knowledge-focused ENROLLING_BY_INVITATIONThis study is trying to find ways to diagnose chronic traumatic encephalopathy (CTE) in living people. Right now, CTE can only be confirmed after death. Researchers will study 350 former college and professional football players, using memory tests and other biomarkers. The goal …
Sponsor: Boston University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Brazilian study investigates why some HIV patients fail key drug combo
Knowledge-focused OngoingThis study tracks 2,500 people with HIV in Brazil who are taking a common first-line treatment (tenofovir/lamivudine and dolutegravir) to see why some develop drug resistance. Researchers will test blood samples from those whose viral load remains detectable to look for resistanc…
Sponsor: Federal University of São Paulo • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Study tests best way to warn about cannabis edibles
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at how different warning labels on cannabis edibles packaging change what people know, how safe they think the product is, and whether they want to try it. About 1,250 adults in the U.S. will view packages with different warnings and answer questions. The goal is…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Brain training for HIV patients: a new hope for sharper thinking?
Knowledge-focused TerminatedThis study aimed to see if personalized computer-based brain exercises could improve thinking skills in adults with HIV who have mild memory or attention problems. Researchers planned to enroll 120 people aged 40 and older, giving half of them training focused on their weakest me…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Mind over knee pain? study probes link between worry and osteoarthritis suffering
Knowledge-focused OngoingThis observational study looks at 103 adults with knee osteoarthritis to see if repetitive negative thinking (rumination and worry) is linked to worse pain and disability, even when X-ray damage is similar. Participants fill out questionnaires about their thoughts, pain, and dail…
Sponsor: Fatih Sultan Mehmet Training and Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Estrogen patches tested for brain effects in eating disorders
Knowledge-focused OngoingThis study looks at whether estrogen patches can improve mental flexibility and reward processing in young women (ages 14-35) with eating disorders linked to low estrogen. About 120 participants will receive either estrogen patches or placebo for 12 weeks. The goal is to understa…
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Daily struggles of hispanic dementia caregivers under the microscope
Knowledge-focused OngoingThis study follows 300 Hispanic and Latino caregivers of relatives with memory problems or dementia. Participants complete daily surveys for three weeks at a time, plus follow-ups at six and twelve months, to track how their mood and stress change day-to-day. The goal is to ident…
Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Teen social media use under the microscope: new study tracks emotional toll
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows 100 teens aged 13-18 who are already enrolled in a depression registry. For 30 days, they report their feelings and social media use twice daily via a phone app, then complete monthly surveys for 6 months. The goal is to understand how social media relates to d…
Sponsor: University of Texas Southwestern Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
New digital tool aims to simplify care for seniors with multiple conditions
Knowledge-focused OngoingThis study tests a web-based tool called gp-multitool.de that helps general practitioners follow guidelines for older patients with multiple chronic conditions. About 659 patients from GP practices in Germany are taking part. The tool lets patients fill out questionnaires online …
Phase: NA • Sponsor: Universitätsklinikum Hamburg-Eppendorf • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Screen time and teen minds: new study probes link
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at how internet habits, cyberbullying, and emotional coping skills relate to mental health in young people aged 15 to 24. Researchers will survey 50 participants about their internet use, depression, anxiety, and self-harm thoughts. The goal is to better understa…
Sponsor: National Taiwan University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:39 UTC
-
Brain scan study aims to spot Alzheimer's years early
Knowledge-focused OngoingThis study follows 640 adults with normal cognition, mild cognitive impairment, or Alzheimer's disease to track brain changes over time. Researchers use advanced brain scans and genetic tests to understand how Alzheimer's develops. The goal is to find better ways to diagnose and …
Sponsor: Seoul National University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Gut bugs linked to antipsychotic weight gain in youth
Knowledge-focused OngoingThis study looks at how gut bacteria change when young people (ages 12-35) with psychosis start taking antipsychotic medication. Researchers want to see if these changes are linked to weight gain and other metabolic problems. Participants provide stool and blood samples over 12 w…
Sponsor: Centre for Addiction and Mental Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Blood test for heavy drinkers put to the test – but study pulled
Knowledge-focused TerminatedThis study aimed to see how well a blood test (phosphatidylethanol) detects heavy alcohol use. Researchers planned to compare test results in heavy drinkers and check how stable the samples are over time. However, the study was withdrawn before enrolling anyone, so no results are…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Can a smartphone app bridge the gap between primary care and addiction treatment?
Knowledge-focused ENROLLING_BY_INVITATIONThis study from Mayo Clinic tests whether a smartphone app called Senyo Health can help connect people with substance use disorders to treatment through their primary care doctor. Sixty participants will use the app for 12 weeks, which includes therapy modules, weekly check-ins w…
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
New imaging study probes brain inflammation in dementia
Knowledge-focused ENROLLING_BY_INVITATIONThis study uses special PET/CT scans to measure inflammation in the brains of people with Alzheimer's disease or Lewy body dementia. Researchers want to see if brain inflammation is linked to memory decline and other dementia symptoms. The study also tests a new radioactive trace…
Phase: PHASE2 • Sponsor: Val Lowe • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Can we predict who ketamine helps? new study aims to find out
Knowledge-focused OngoingThis study aims to find which patients with treatment-resistant depression are most likely to get relief from a single low dose of IV ketamine. Researchers will use interviews, questionnaires, brain wave tests, and computer tasks to look for clues. The goal is to make this treatm…
Phase: PHASE3 • Sponsor: Abraham Nunes • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Scientists probe Brain's depression hub with magnetic pulses
Knowledge-focused OngoingThis study looks at how transcranial magnetic stimulation (TMS) affects a brain area called the subgenual cingulate, which is linked to depression. Researchers will give 54 adults with depression daily TMS sessions for 4-6 weeks, along with MRI scans, to see how this brain region…
Phase: NA • Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Talking it out: parent group aims to curb disordered eating in teens
Knowledge-focused OngoingThis study looks at whether a single 2-hour group discussion for parents and caregivers can improve eating habits, mood, and parent-child relationships. About 112 Oregon parents of teens (ages 12-17) will either join the talk now or wait. Researchers will measure changes in both …
Phase: NA • Sponsor: University of Oregon • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Rare disease mystery: NIH launches deep dive into Smith-Magenis syndrome
Knowledge-focused OngoingThis study follows nearly 600 people with Smith-Magenis syndrome (SMS), a rare genetic condition, to track how their health, behavior, and development change over time. Researchers will perform detailed medical exams, genetic tests, and surveys to better understand the syndrome's…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Ketamine's brain secrets: new study aims to unlock rapid depression relief
Knowledge-focused OngoingThis study gives ketamine to 120 people with major depression and suicidal thoughts who are not on other psychiatric medications. Researchers use brain scans and a gentle nose swab to see how ketamine changes brain connections and neuron activity. The goal is to understand why ke…
Phase: PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Brain scans reveal Stress's toll on aging minds
Knowledge-focused OngoingThis study looks at how stress influences long-term mood and thinking in 75 older adults with depression. Participants receive standard antidepressant treatment while researchers track their depression severity, memory, and brain activity using MRI scans. The goal is to understan…
Phase: PHASE4 • Sponsor: David Steffens • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Can pediatrician training improve Parent-Child bonds?
Knowledge-focused OngoingThis study looks at whether training pediatricians to assess how mothers and babies interact can help identify early signs of child behavior issues or postpartum depression. Over 3,500 mother-child pairs are involved, with babies seen at their one-month checkup. The goal is to se…
Phase: NA • Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Scientists zap brains to unlock joy in depressed patients
Knowledge-focused ENROLLING_BY_INVITATIONThis study explores how a specific brain area (the medial prefrontal cortex) influences the ability to savor positive experiences in people with depression. Researchers will use non-invasive brain stimulation (TMS) and brain scans (EEG and fMRI) to see if changing activity in thi…
Phase: NA • Sponsor: Florida State University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Study pulled: music and meditation for heart bypass recovery never tested
Knowledge-focused TerminatedThis study aimed to see if music therapy and mindfulness meditation could help people who had coronary artery bypass surgery improve their blood pressure, heart rate, anxiety, and depression. It planned to enroll 48 adults who had the surgery and were stable. However, the study w…
Phase: NA • Sponsor: Universiti Tunku Abdul Rahman • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Fixing sleep may calm Alzheimer's-Related mood swings, study hints
Knowledge-focused OngoingThis study looks at whether improving sleep through cognitive behavioral therapy (CBT-I) can reduce neuropsychiatric symptoms like anxiety, depression, and agitation in 150 older adults with mild cognitive impairment or early Alzheimer's. Participants are randomly assigned to CBT…
Phase: NA • Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
At-Home blood test for Alzheimer's risk studied in seniors
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at whether adults aged 65 and older with memory concerns can collect a small blood sample at home to check for Alzheimer's disease risk. Participants will use a simple device to draw blood, mail it to a lab, and get results from a doctor over video. The goal is t…
Sponsor: University of Virginia • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
MDMA brain study on PTSD never got off the ground
Knowledge-focused TerminatedThis study aimed to see how MDMA changes brain activity in people with PTSD, especially in areas that handle emotions. Researchers planned to give MDMA to a small group and measure brain scans and PTSD symptoms. However, the study was withdrawn before any participants were enroll…
Phase: PHASE1 • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Your phone may predict dementia before you notice
Knowledge-focused OngoingThis study explores whether smartphone sensors can detect early changes in behavior that might signal cognitive decline. About 100 adults aged 65 and older living in assisted living facilities will have an app on their phones that tracks movement, typing patterns, and app usage f…
Sponsor: Soroka University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Your phone could help design your therapy: new study tests personalized CBT for anxiety and drinking
Knowledge-focused ENROLLING_BY_INVITATIONThis study uses smartphone data to understand what triggers anxiety and alcohol use in each person, then tailors therapy to those specific triggers. 81 adults with anxiety and alcohol problems will receive 11 sessions of cognitive behavioral therapy (CBT) either personalized to t…
Phase: NA • Sponsor: Rutgers, The State University of New Jersey • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Ultrasound-Guided epidurals: a missed opportunity?
Knowledge-focused TerminatedThis study aimed to see if using real-time ultrasound during a thoracic epidural block makes the procedure more reliable. It was designed for adults with chest or abdominal pain or rib fractures. The study was withdrawn before enrolling any participants, so no results are availab…
Sponsor: University of Chile • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Can tracking rigid thoughts improve addiction treatment?
Knowledge-focused ENROLLING_BY_INVITATIONThis study observes 35 people in residential treatment for substance use disorders to measure behavioral rigidity—the tendency to get stuck in inflexible thinking patterns. Participants complete weekly questionnaires and have their therapy sessions analyzed for language patterns.…
Sponsor: Lauro Gutiérrez Castro • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Smart home tech could spot early dementia signs
Knowledge-focused OngoingThis Stanford study is testing whether non-intrusive sensors placed in the home can automatically track neuropsychiatric symptoms like mood changes and agitation in older adults. Researchers will enroll 25 participants with or at risk of mild cognitive impairment or dementia, alo…
Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
1600 people with opioid addiction to be tracked for years to uncover secrets of recovery
Knowledge-focused OngoingThis study follows 1600 adults with opioid use disorder over the long term by collecting monthly online surveys and yearly phone interviews. Researchers will track substance use, mental health, treatment involvement, and daily functioning. The goal is to better understand how peo…
Sponsor: Mclean Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Depression dose study pulled before starting
Knowledge-focused TerminatedThis study aimed to see if measuring sertraline (Zoloft) levels in the blood and checking a specific gene (CYP2C19) could help doctors give the right dose to people with major depression. The goal was to reduce side effects and improve treatment. However, the study was withdrawn …
Sponsor: University of Belgrade • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Smartwatches and apps could spot dementia decades early
Knowledge-focused OngoingThis study looks at whether people with memory problems will wear and use digital devices like smartwatches, sleep headbands, and smartphone apps to collect health data. Researchers will combine this data with clinical information to build machine learning models that might one d…
Sponsor: University College, London • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Can salvation army staff help smokers quit? new study aims to find out
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at how Salvation Army staff can help people who smoke learn about and use free quit-smoking services, like the Wisconsin Tobacco Quit Line. Researchers will train staff to offer a short survey that gives feedback on smoking risks and treatment options. The goal i…
Phase: NA • Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC